<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60351</article-id><article-id pub-id-type="doi">10.7554/eLife.60351</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title><italic>Cdon</italic> mutation and fetal alcohol converge on Nodal signaling in a mouse model of holoprosencephaly</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-195881"><name><surname>Hong</surname><given-names>Mingi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195882"><name><surname>Christ</surname><given-names>Annabel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195883"><name><surname>Christa</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195884"><name><surname>Willnow</surname><given-names>Thomas E</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-138768"><name><surname>Krauss</surname><given-names>Robert S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7661-3335</contrib-id><email>Robert.Krauss@mssm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Max-Delbruck-Center for Molecular Medicine</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bovolenta</surname><given-names>Paola</given-names></name><role>Reviewing Editor</role><aff><institution>CSIC-UAM</institution><country>Spain</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution>California Institute of Technology</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>02</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e60351</elocation-id><history><date date-type="received" iso-8601-date="2020-07-03"><day>03</day><month>07</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-08-10"><day>10</day><month>08</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Hong et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Hong et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60351-v1.pdf"/><abstract><p>Holoprosencephaly (HPE), a defect in midline patterning of the forebrain and midface, arises ~1 in 250 conceptions. It is associated with predisposing mutations in the Nodal and Hedgehog (HH) pathways, with penetrance and expressivity graded by genetic and environmental modifiers, via poorly understood mechanisms. CDON is a multifunctional co-receptor, including for the HH pathway. In mice, <italic>Cdon</italic> mutation synergizes with fetal alcohol exposure, producing HPE phenotypes closely resembling those seen in humans. We report here that, unexpectedly, Nodal signaling is a major point of synergistic interaction between <italic>Cdon</italic> mutation and fetal alcohol. Window-of-sensitivity, genetic, and in vitro findings are consistent with a model whereby brief exposure of <italic>Cdon</italic> mutant embryos to ethanol during gastrulation transiently and partially inhibits Nodal pathway activity, with consequent effects on midline patterning. These results illuminate mechanisms of gene-environment interaction in a multifactorial model of a common birth defect.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>A common birth defect known as holoprosencephaly affects how the brain and face of a fetus develop in the womb. In many cases, the condition is so severe that the fetus dies before, or shortly after, birth. Mutations in certain genes that control how the fetus develops are associated with holoprosencephaly. For example, mutations in components of the Hedgehog and Nodal signaling pathways, which transmit information that help cells to become specialized, increase the risk that a fetus will develop holoprosencephaly. Environmental factors, such as exposure to alcohol in the womb, are also thought to contribute to this condition.</p><p>A gene known as <italic>Cdon</italic> is a component of the Hedgehog signaling pathway. In 2012, a team of researchers reported that mice with a mutation in the <italic>Cdon</italic> gene exposed to alcohol in the womb develop symptoms similar to holoprosencephaly in humans. Here, Hong et al. – including some of the researchers involved in the previous work – set out to understand how <italic>Cdon</italic> and alcohol work together to cause holoprosencephaly in the mutant mice.</p><p>First, the team exposed pregnant mice to alcohol at different times during gestation to find out when their young were sensitive to developing holoprosencephaly. This showed that the young mice were most sensitive in early pregnancy when the Nodal pathway was active in their growing bodies. Further experiments found that alcohol and mutations in <italic>Cdon</italic> change Nodal signaling in cells. Together, these findings demonstrate that exposure to alcohol in the womb works together with the mutant form of <italic>Cdon</italic> via the Nodal signaling pathway, rather than the Hedgehog pathway, to cause holoprosencephaly in mice.</p><p>The causes of many common birth defects are complex and difficult to distinguish at the level of individual cases. The work of Hong et al. illuminates how multiple risk factors during pregnancy, which may not create any problems on their own, may work together to produce birth defects in the fetus. The findings also offer new ways to understand how exposure to alcohol in the womb affects the fetus. Ultimately, understanding how birth defects form could lead to new strategies to prevent them in the future.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>holoprosencephaly</kwd><kwd>fetal alcohol</kwd><kwd>birth defect</kwd><kwd>Nodal signaling</kwd><kwd>hedgehog signaling</kwd><kwd>gene-environment interaction</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000072</institution-id><institution>National Institute of Dental and Craniofacial Research</institution></institution-wrap></funding-source><award-id>DE024748</award-id><principal-award-recipient><name><surname>Krauss</surname><given-names>Robert S</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>German Research Foundation</institution></institution-wrap></funding-source><award-id>CH1838/1-1</award-id><principal-award-recipient><name><surname>Christ</surname><given-names>Annabel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A combination of window-of-sensitivity, genetic, and in vitro findings illuminate mechanisms of gene–environment interaction in a multifactorial model of a common birth defect.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Many common structural birth defects appear to arise from a complex and ill-defined combination of genetic and environmental factors (<xref ref-type="bibr" rid="bib49">Krauss and Hong, 2016</xref>). The notion that environmental agents affect penetrance and expressivity of predisposing mutations is speculated to underlie many human congenital anomalies, but has been difficult to demonstrate. Animal models are therefore valuable, but these have been slow to emerge. Some recent successful examples are a zebrafish model of craniofacial defects (<italic>Pdgfra</italic> mutations and fetal alcohol), and mouse models of scoliosis (Notch pathway mutations plus hypoxia), facial clefting (<italic>Pax3</italic> mutations plus 2,3,7,8-tetrachlorodibenzodioxin (TCDD)), and holoprosencephaly (Hedgehog pathway mutations and fetal alcohol) (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>; <xref ref-type="bibr" rid="bib45">Kietzman et al., 2014</xref>; <xref ref-type="bibr" rid="bib65">McCarthy et al., 2013</xref>; <xref ref-type="bibr" rid="bib93">Sparrow et al., 2012</xref>; <xref ref-type="bibr" rid="bib103">Zalc et al., 2015</xref>).</p><p>Holoprosencephaly (HPE) is a common developmental defect in midline patterning of the forebrain and/or midface (<xref ref-type="bibr" rid="bib69">Muenke and Beachy, 2001</xref>). HPE occurs approximately once per 250 human conceptions, with an associated in utero lethality of ~97% (<xref ref-type="bibr" rid="bib53">Leoncini et al., 2008</xref>; <xref ref-type="bibr" rid="bib89">Shiota and Yamada, 2010</xref>). HPE is characterized by an unbroken continuum of rostroventral midline anomalies that range from complete failure to partition the forebrain into hemispheres plus cyclopia, through progressively less severe defects including partially partitioned forebrain, single nostril, and midface hypoplasia (<xref ref-type="bibr" rid="bib18">Cohen, 2006</xref>; <xref ref-type="bibr" rid="bib48">Krauss, 2007</xref>; <xref ref-type="bibr" rid="bib69">Muenke and Beachy, 2001</xref>).</p><p>Development of the rostroventral midline is initiated by signals derived from the prechordal plate (PCP) (<xref ref-type="bibr" rid="bib44">Kiecker and Niehrs, 2001</xref>; <xref ref-type="bibr" rid="bib60">Marcucio et al., 2011</xref>). The PCP produces Sonic hedgehog (SHH), initiating a sequence of events that progressively patterns the forebrain and midface (<xref ref-type="bibr" rid="bib7">Aoto et al., 2009</xref>; <xref ref-type="bibr" rid="bib22">Cordero et al., 2004</xref>; <xref ref-type="bibr" rid="bib30">Geng and Oliver, 2009</xref>; <xref ref-type="bibr" rid="bib44">Kiecker and Niehrs, 2001</xref>; <xref ref-type="bibr" rid="bib85">Rubenstein and Beachy, 1998</xref>; <xref ref-type="bibr" rid="bib105">Zhang et al., 2006</xref>). HH ligands trigger signaling by binding the primary receptor Patched1 (PTCH1). In the absence of ligand, PTCH1 constrains the activity of a second membrane protein, Smoothened (SMO). HH binding inhibits PTCH1 function, allowing SMO-dependent signals to activate GLI transcription factors and pathway-specific gene expression. HH ligand availability and signal reception are also regulated by a series of co-receptors and additional HH-binding proteins, including CDON, BOC, GAS1, and LRP2 (<xref ref-type="bibr" rid="bib11">Beachy et al., 2010</xref>; <xref ref-type="bibr" rid="bib47">Kong et al., 2019</xref>; <xref ref-type="bibr" rid="bib52">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Petrov et al., 2017</xref>; <xref ref-type="bibr" rid="bib102">Willnow and Christ, 2017</xref>).</p><p>The PCP develops from the anterior primitive streak (APS) under the influence of Nodal pathway signaling (<xref ref-type="bibr" rid="bib82">Robertson, 2014</xref>; <xref ref-type="bibr" rid="bib87">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib88">Shen, 2007</xref>). Therefore, the Nodal pathway is developmentally upstream of the HH pathway in rostroventral midline patterning. Consistent with this conclusion, defective Nodal signaling at the primitive streak stage of development leads to defects in HH signaling and HPE (<xref ref-type="bibr" rid="bib48">Krauss, 2007</xref>). Nodal is a TGFβ superfamily member and signals through a receptor complex including the type I and type II receptors, ALK4 and Activin receptor IIA/B (ActRIIA/B), and a GPI-linked co-receptor, TDGF1 (also called Cripto) (<xref ref-type="bibr" rid="bib82">Robertson, 2014</xref>; <xref ref-type="bibr" rid="bib87">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib88">Shen, 2007</xref>). Receptor activation results in phosphorylation of the transcription factors SMAD2 and SMAD3, and activation of genes required for PCP induction (<xref ref-type="bibr" rid="bib82">Robertson, 2014</xref>; <xref ref-type="bibr" rid="bib87">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib88">Shen, 2007</xref>). Among these genes are <italic>Foxa2</italic> and <italic>Gsc</italic> (<xref ref-type="bibr" rid="bib5">Ang and Rossant, 1994</xref>; <xref ref-type="bibr" rid="bib12">Belo et al., 1998</xref>; <xref ref-type="bibr" rid="bib29">Filosa et al., 1997</xref>). Nodal signaling also induces expression of <italic>Lefty1</italic> and <italic>Lefty2</italic>, which encode secreted inhibitors of the pathway that bind to TDGF1 and Nodal itself (<xref ref-type="bibr" rid="bib82">Robertson, 2014</xref>; <xref ref-type="bibr" rid="bib87">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib88">Shen, 2007</xref>).</p><p>The etiology of HPE is complex, involving both genetic and environmental risk factors (<xref ref-type="bibr" rid="bib2">Addissie et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Dubourg et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Hong and Krauss, 2018</xref>; <xref ref-type="bibr" rid="bib40">Johnson and Rasmussen, 2010</xref>; <xref ref-type="bibr" rid="bib48">Krauss, 2007</xref>; <xref ref-type="bibr" rid="bib73">National Birth Defects Prevention Study et al., 2010</xref>; <xref ref-type="bibr" rid="bib69">Muenke and Beachy, 2001</xref>; <xref ref-type="bibr" rid="bib74">NISC Comparative Sequencing Program et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Roessler et al., 2018</xref>; <xref ref-type="bibr" rid="bib96">Summers et al., 2018</xref>). Heterozygous, loss-of-function mutations in components or regulators of the HH, Nodal, and FGF signaling pathways are associated with HPE (<xref ref-type="bibr" rid="bib74">NISC Comparative Sequencing Program et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Roessler et al., 2018</xref>). Epidemiology of HPE is less advanced than genetic analyses, but among the environmental risk factors implicated is fetal alcohol exposure (<xref ref-type="bibr" rid="bib1">Abe et al., 2018</xref>; <xref ref-type="bibr" rid="bib19">Cohen and Shiota, 2002</xref>; <xref ref-type="bibr" rid="bib23">Croen et al., 2000</xref>), though this is not always observed (<xref ref-type="bibr" rid="bib2">Addissie et al., 2020</xref>). A full range of clinical phenotypes is seen in both sporadic and familial HPE (<xref ref-type="bibr" rid="bib69">Muenke and Beachy, 2001</xref>; <xref ref-type="bibr" rid="bib90">Solomon et al., 2010</xref>). Many mutation carriers in pedigrees lack clinical manifestation, and many apparently sporadic cases have inherited a mutation from a minimally affected parent (<xref ref-type="bibr" rid="bib51">Lacbawan et al., 2009</xref>; <xref ref-type="bibr" rid="bib91">Solomon et al., 2012</xref>). It is likely, therefore, that HPE-associated mutations are not sufficient to produce midline defects, but are the substrate on which a complex landscape of genetic and/or environmental modifiers act. Statistical analysis is consistent with a multifactorial, ‘autosomal dominant with modifier’ model, wherein the penetrance and expressivity of a heterozygous driver mutation is graded by the modifier landscape (<xref ref-type="bibr" rid="bib27">Dubourg et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Hong and Krauss, 2018</xref>; <xref ref-type="bibr" rid="bib83">Roessler et al., 2012</xref>).</p><p>We have modeled this phenomenon in mice with high fidelity. <italic>CDON</italic> encodes a multi-functional co-receptor, including for the HH pathway, (<xref ref-type="bibr" rid="bib58">Lu and Krauss, 2010</xref>; <xref ref-type="bibr" rid="bib86">Sanchez-Arrones et al., 2012</xref>). <italic>CDON</italic> loss-of-function mutations have been identified in human HPE patients (<xref ref-type="bibr" rid="bib9">Bae et al., 2011</xref>; <xref ref-type="bibr" rid="bib74">NISC Comparative Sequencing Program et al., 2018</xref>), but such variants are relatively common in the human population. Additionally, a patient with a rare homozygous <italic>CDON</italic> mutation displayed retinal coloboma, a mild HPE-associated eye phenotype also seen in <italic>Cdon<sup>-/-</sup></italic> mice (<xref ref-type="bibr" rid="bib13">Berkun et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Pineda-Alvarez et al., 2011</xref>; <xref ref-type="bibr" rid="bib106">Zhang et al., 2009</xref>). Therefore, <italic>CDON</italic> mutations likely require additional insults to contribute to HPE. Studies with mice are consistent with this conclusion. <italic>Cdon<sup>-/-</sup></italic> mice on a 129S6 genetic background have a subthreshold defect in HH signaling and are subject to HPE induced by genetic and environmental modifiers; among the latter is ethanol (EtOH) (<xref ref-type="bibr" rid="bib36">Hong and Krauss, 2018</xref>). <italic>Cdon</italic> mutation or in utero EtOH exposure individually yielded little effect on 129S6 mice. The combination, however, synergized to inhibit HH signaling in the developing forebrain and produced a complete spectrum of HPE phenotypes with high penetrance (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). Furthermore, fetal EtOH induced a low penetrance of HPE in C57BL/6J mice, and this was exacerbated by heterozygosity for <italic>Shh</italic> or <italic>Gli2</italic> (<xref ref-type="bibr" rid="bib45">Kietzman et al., 2014</xref>). Consistent with the notion that a threshold of HH signaling activity is rate-limiting in midline patterning, genetic removal of one copy of the negative pathway regulator, <italic>Ptch1</italic>, rescued 129S6 <italic>Cdon<sup>-/-</sup></italic> mice from EtOH-induced HPE (<xref ref-type="bibr" rid="bib34">Hong and Krauss, 2013</xref>).</p><p>Defective HH pathway function may be a final common mechanism for all classical forms of HPE, so these results do not prove that HH signaling is the direct synergistic target of <italic>Cdon</italic> mutation and in utero EtOH exposure. Several lines of evidence argue that EtOH itself, rather than a consequence of its metabolism, is the HPE-inducing teratogen (<xref ref-type="bibr" rid="bib35">Hong and Krauss, 2017</xref>). In this study, we demonstrate that the window of sensitivity to EtOH-induced HPE in 129S6 <italic>Cdon<sup>-/-</sup></italic> mice is closed by embryonic day (E) 7.5, with the sensitivity period overlapping Nodal-mediated specification of the PCP from the APS. Furthermore, we find that CDON interacts genetically and physically with regulators of Nodal signaling. Finally, EtOH inhibits Activin/Nodal pathway signaling in vitro in mouse epiblast stem cells (mEpiSCs), which have transcriptional and functional properties that resemble APS cells (<xref ref-type="bibr" rid="bib46">Kojima et al., 2014</xref>; <xref ref-type="bibr" rid="bib98">Tsakiridis et al., 2014</xref>). Together these results argue that, unexpectedly, <italic>Cdon</italic> mutation and fetal alcohol synergize to induce HPE by interfering with Nodal signaling. These results illuminate mechanisms of gene-environment interaction in a high fidelity, multifactorial model of a common birth defect.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The window of sensitivity to EtOH-induced HPE coincides with Nodal signaling</title><p>All studies were performed with mice on a 129S6 background and are referred to only by genotype unless otherwise noted. Our model uses one-hour timed mating of <italic>Cdon<sup>+/-</sup></italic> mice, allowing rigorous identification of a window of sensitivity for EtOH’s teratogenic effects. The standard EtOH treatment regimen involves one dose at E7.0 and a second dose four hours later. This results in a full range of HPE phenotypes in <italic>Cdon<sup>-/-</sup></italic> mice with overall penetrance of ~75% (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). The protocol is analogous to the original regimen developed to model fetal alcohol spectrum disorders in C57BL/6J mice, wherein ~ 19% developed HPE phenotypes (<xref ref-type="bibr" rid="bib6">Aoto et al., 2008</xref>; <xref ref-type="bibr" rid="bib95">Sulik et al., 1981</xref>). HPE phenotypes were not induced in wild type C57BL/6J mice when EtOH was administered at E6.5 or E7.5 (<xref ref-type="bibr" rid="bib6">Aoto et al., 2008</xref>). We have shown that EtOH is ineffective in <italic>Cdon<sup>-/-</sup></italic> mice when administered at E8.0 (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). To further refine the temporal window of sensitivity, we assessed the ability of EtOH to induce HPE in <italic>Cdon<sup>-/-</sup></italic> animals when administered at E7.25 and E7.5, with embryos examined for external HPE phenotypes at E14.0. EtOH was effective at E7.25, but not at E7.5 (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Time course of EtOH-Induced HPE in <italic>Cdon<sup>-/-</sup></italic> Embryos.</title><p>Frontal views of E14.0 embryos. Treatment of <italic>Cdon<sup>-/-</sup></italic> embryos with EtOH at E7.25, but not E7.5, results in HPE (see <xref ref-type="table" rid="table1">Table 1</xref> for quantification). The <italic>Cdon<sup>-/-</sup></italic>embryo treated with EtOH at E7.25 displays a fused upper lip and single nostril (black arrow), whereas the <italic>Cdon<sup>-/-</sup></italic>embryo treated with EtOH at E7.5 does not and resembles the saline control (red arrow).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig1-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Time course of EtOH-Induced HPE in <italic>Cdon<sup>-/-</sup></italic> Embryos</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">EtOH treatment:</th><th colspan="4" valign="top">E7.25</th><th colspan="2" valign="top">E7.5</th></tr><tr><th valign="top"/><th colspan="2" valign="top">Saline</th><th colspan="2" valign="top">EtOH</th><th colspan="2" valign="top">EtOH</th></tr></thead><tbody><tr><td valign="top">Phenotype*</td><td valign="top"><italic>Cdon<sup>+/-</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup></italic></td><td valign="top"><italic>Cdon<sup>+/-</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup></italic></td><td valign="top"><italic>Cdon<sup>+/-</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup></italic></td></tr><tr><td valign="top">Fused upper lip</td><td valign="top">0/17</td><td valign="top">2/14</td><td valign="top">0/21</td><td valign="top">13/24**</td><td valign="top">0/13</td><td valign="top">0/22</td></tr><tr><td valign="top">Single nostril</td><td valign="top">0/17</td><td valign="top">0/14</td><td valign="top">0/21</td><td valign="top">5/24</td><td valign="top">0/13</td><td valign="top">0/22</td></tr><tr><td valign="top">Proboscis</td><td valign="top">0/17</td><td valign="top">0/14</td><td valign="top">0/21</td><td valign="top">2/24</td><td valign="top">0/13</td><td valign="top">0/22</td></tr></tbody></table><table-wrap-foot><fn><p>* All embryos with HPE had fused upper lip, a fraction of these showed single nostril and proboscis.</p><p>**p=0.0165 by Fisher’s two-tailed exact test, when compared to EtOH-treated <italic>Cdon<sup>+/-</sup></italic> embryos.</p></fn></table-wrap-foot></table-wrap><p>EtOH itself is the HPE-inducing teratogen in this system (<xref ref-type="bibr" rid="bib35">Hong and Krauss, 2017</xref>). The developmental processes directly perturbed by EtOH must therefore occur: 1) during the sensitive time window; and 2) prior to EtOH clearance, even if defects in midline development occur later. When administered at E7.0, maternal blood EtOH levels peaked at E7.25 and were no longer detectable by ~E7.75 (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). Critically, EtOH is no longer effective at E7.5, a time reported to be prior to SHH expression and function in prechordal plate-mediated rostroventral midline patterning (<xref ref-type="bibr" rid="bib28">Echelard et al., 1993</xref>; <xref ref-type="bibr" rid="bib67">McMahon et al., 2003</xref>). These results argue that EtOH targets processes other than, or in addition to, HH signaling in <italic>Cdon<sup>-/-</sup></italic> mice. Consistent with this conclusion, the time of peak sensitivity to HPE induced by the direct SMO inhibitor, Vismodegib, was E7.5, 6–12 hr later than for EtOH (<xref ref-type="bibr" rid="bib32">Heyne et al., 2015</xref>).</p><p>Both the window of sensitivity to EtOH and peak EtOH levels overlap with induction of the PCP by Nodal signaling. We previously observed that expression of <italic>Foxa2</italic> and <italic>Gsc</italic>, two Nodal target genes that mark the APS (from which the PCP is derived), was diminished at E7.25 in EtOH-treated <italic>Cdon<sup>-/-</sup></italic> embryos (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). Both <italic>Cdon</italic> mutation and EtOH exposure were required for this effect. Expression of <italic>Lefty2</italic>, a direct Nodal pathway target gene, was also reduced at E7.25 specifically in EtOH-treated <italic>Cdon<sup>-/-</sup></italic> embryos (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Taken together, these results showed that the synergy between <italic>Cdon</italic> mutation and in utero EtOH exposure occurred during Nodal-dependent specification of the PCP and that reduction of Nodal target gene expression required a combination of mutation and teratogen. The observation that loss of CDON was required for the effect suggests that, in addition to its role as a SHH co-receptor, CDON functions earlier in development to promote midline patterning, potentially via the Nodal pathway. In fact, <italic>Cdon</italic> expression initiates during gastrulation and is seen in embryonic mesoderm and ectoderm (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>; <xref ref-type="bibr" rid="bib70">Mulieri et al., 2000</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Defective Expression of <italic>Lefty2</italic> at the Primitive Streak Stage of EtOH-Treated <italic>Cdon<sup>-/-</sup></italic> Embryos.</title><p>Whole mount in situ hybridization analyses of <italic>Lefty2</italic> in embryos of the indicated genotype and treatment harvested at E7.25. <italic>Lefty2</italic> expression was decreased specifically in EtOH-treated <italic>Cdon<sup>-/-</sup></italic> embryos. Numbers of embryos with similar results: <italic>Cdon<sup>+/-</sup></italic> (saline) = 6; <italic>Cdon<sup>+/-</sup></italic> (EtOH) = 4; <italic>Cdon<sup>-/-</sup></italic> (saline) = 9; <italic>Cdon<sup>-/-</sup></italic> (EtOH) = 9. Scale Bar, 200 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig2-v1.tif"/></fig></sec><sec id="s2-2"><title><italic>Cdon</italic> interacts genetically with Nodal pathway components</title><p>Mice with mutations resulting in complete loss of Nodal signaling gastrulate abnormally and die early in development, but hypomorphic pathway mutants display a range of HPE phenotypes (<xref ref-type="bibr" rid="bib4">Andersson et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Chu et al., 2005</xref>; <xref ref-type="bibr" rid="bib57">Lowe et al., 2001</xref>; <xref ref-type="bibr" rid="bib75">Nomura and Li, 1998</xref>; <xref ref-type="bibr" rid="bib87">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib88">Shen, 2007</xref>; <xref ref-type="bibr" rid="bib92">Song et al., 1999</xref>). To further probe the linkage between CDON and regulation of Nodal signaling, we assessed whether <italic>Cdon</italic> interacted genetically with <italic>Tdgf1</italic> and <italic>Lefty2</italic>, direct positive and negative regulators of the Nodal pathway, respectively. When analyzed at E10,~14% of <italic>Cdon<sup>-/-</sup></italic> embryos treated with EtOH had alobar HPE and cyclopia, dying in utero by E11 (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>; <xref ref-type="bibr" rid="bib34">Hong and Krauss, 2013</xref>). When studied at E14,~70% of such embryos displayed lobar HPE and a range of craniofacial midline phenotypes, including fused upper lip and single nostril (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>; <xref ref-type="bibr" rid="bib34">Hong and Krauss, 2013</xref>). To address genetic interactions between <italic>Cdon</italic> and Nodal pathway regulators, we took advantage of the high penetrance of phenotypes at E14 and analyzed embryos at this stage for these unambiguous, easily scored phenotypes.</p><p>Targeted mutations in <italic>Tdgf1</italic> and <italic>Lefty2</italic> (<xref ref-type="bibr" rid="bib25">Ding et al., 1998</xref>; <xref ref-type="bibr" rid="bib68">Meno et al., 1999</xref>) were placed onto the 129S6 genetic background and then crossed to <italic>Cdon</italic> mutants to generate double heterozygotes. Offspring of intercrosses of these mice were further crossed and pregnant females were treated with EtOH or saline as a control. <italic>Tdgf1</italic> is essential for Nodal signaling. <italic>Lefty2</italic> is induced in response to Nodal signaling to provide critical negative feedback as an inhibitor of the pathway. Since CDON and EtOH may act together at the level of Nodal signaling in HPE, we predicted that removal of one copy of <italic>Tdgf1</italic> would sensitize <italic>Cdon<sup>-/-</sup></italic> embryos to EtOH-induced HPE. In contrast, removal of one copy of <italic>Lefty2</italic> would be predicted to rescue <italic>Cdon<sup>-/-</sup></italic> embryos from EtOH-induced HPE. (Null mutations in <italic>Tdgf1</italic> and <italic>Lefty2</italic> result in early lethality due to strong gastrulation defects (<xref ref-type="bibr" rid="bib25">Ding et al., 1998</xref>; <xref ref-type="bibr" rid="bib68">Meno et al., 1999</xref>), so studying homozygous double mutants with <italic>Cdon</italic> is impossible.) To permit the detection of sensitization by <italic>Tdgf1</italic> heterozygosity, we used a dose of EtOH which we previously reported gives ~30% penetrance of HPE at E14 (2.9 g/kg) (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). With this regimen, 28% of EtOH-treated <italic>Cdon<sup>-/-</sup>;Tdgf1<sup>+/+</sup></italic> embryos had HPE, whereas 55% of <italic>Cdon<sup>-/-</sup>;Tdgf1<sup>+/-</sup></italic> embryos did (p&lt;0.014) (<xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>). With the exception of a single EtOH-treated <italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic> embryo, EtOH-treated mice of other genotypes and saline-treated control mice did not display HPE. Removal of one copy of <italic>Tdgf1</italic> therefore sensitized <italic>Cdon<sup>-/-</sup></italic> mice to EtOH-induced HPE.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title><italic>Tdgf1</italic> Heterozygosity Enhances EtOH-Induced HPE in <italic>Cdon<sup>-/-</sup></italic> Embryos.</title><p>Frontal views of E14.0 embryos. Removal of one copy of <italic>Tdgf1</italic> enhanced the response of <italic>Cdon<sup>-/-</sup></italic> embryos to a dose of 2.9 g/kg EtOH (see <xref ref-type="table" rid="table2">Table 2</xref> for quantification). The EtOH-treated <italic>Cdon<sup>-/-</sup>;Tdgf1<sup>+/-</sup></italic> embryo displays a fused upper lip (arrow).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig3-v1.tif"/></fig><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title><italic>Tdgf1</italic> Heterozygosity Enhances EtOH-Induced HPE in <italic>Cdon<sup>-/-</sup></italic> Embryos.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Treatment</th><th colspan="4" valign="top">Genotype (# embryos with HPE/total (%))*</th></tr></thead><tbody><tr><td valign="top"/><td colspan="2" valign="top"><italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup>;Tdgf1<sup>+/+</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup>;Tdgf1<sup>+/-</sup></italic></td></tr><tr><td valign="top">Saline</td><td colspan="2" valign="top">0/23 (0%)</td><td valign="top">0/11 (0%)</td><td valign="top">2/27 (7.4%)</td></tr><tr><td valign="top">EtOH (2.9 g/kg)</td><td colspan="2" valign="top">1/48 (2.1%)</td><td valign="top">9/32 (28.1%)</td><td valign="top">31/56 (55.4%)**</td></tr></tbody></table><table-wrap-foot><fn><p>* Crosses between the following genotypes were used to generate the genotypes scored above:</p><p><italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic> x <italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic>.</p></fn><fn><p><italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic> x <italic>Cdo-<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic>.</p><p><italic>Cdon<sup>+/-</sup></italic> x <italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic>.</p></fn><fn><p><italic>Cdon<sup>+/-</sup></italic> x <italic>Cdon<sup>-/-</sup>;Tdgf1<sup>+/-</sup></italic>.</p><p><italic>Cdon<sup>-/-</sup></italic> x <italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic>.</p></fn><fn><p>No HPE was found in offspring genotypes other than those shown.</p><p>** p=0.014 by Fisher's two-tailed exact test, when compared to EtOH-treated <italic>Cdon<sup>-/-</sup>; Tdgf1</italic> <sup>+/+</sup> embryos.</p></fn></table-wrap-foot></table-wrap><p><italic>Nodal<sup>-/-</sup></italic> and <italic>Lefty2<sup>-/-</sup></italic> embryos have opposite defects in gastrulation and display dosage-dependent genetic interactions, with <italic>Lefty2</italic> functioning as a negative regulator of the pathway (<xref ref-type="bibr" rid="bib68">Meno et al., 1999</xref>). To test for phenotypic suppression in EtOH-induced HPE, we used the standard dose of EtOH (3.48 g/kg) for these analyses, as it results in high penetrance. All embryos with HPE at E14 display a fused upper lip, while only some show the more severe single nostril phenotype. Approximately 70% of EtOH-treated <italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/+</sup></italic> embryos had a fused upper lip, similar to our previous findings (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>; <xref ref-type="bibr" rid="bib34">Hong and Krauss, 2013</xref>), whereas 54% of <italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/-</sup></italic> embryos did, revealing a trend toward overall reduction of HPE frequency (p=0.14). However, while 21% of EtOH-treated <italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/+</sup></italic> embryos had a single nostril, only 6% of <italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/-</sup></italic> embryos did (p=0.04) (<xref ref-type="table" rid="table3">Table 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref> ). Again, EtOH-treated mice of other genotypes and saline-treated control mice did not display HPE. Therefore, removal of one copy of <italic>Lefty2</italic> rescued a more severe form of HPE associated with EtOH treatment. Taken together, these studies revealed that the Nodal signaling components <italic>Tdgf1</italic> and <italic>Lefty2</italic> act as heterozygous enhancer and suppressor genes, respectively, of EtOH-induced HPE in <italic>Cdon<sup>-/-</sup></italic> embryos.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Lefty2</italic> Heterozygosity Suppresses EtOH-Induced HPE in <italic>Cdon<sup>-/-</sup></italic> Embryos.</title><p>Frontal views of E14.0 embryos. Removal of one copy of <italic>Lefty2</italic> suppressed formation of single nostril in <italic>Cdon<sup>-/-</sup></italic> embryos in response to a dose of 3.48 g/kg EtOH (see <xref ref-type="table" rid="table3">Table 3</xref> for quantification). The EtOH-treated <italic>Cdon<sup>-/-</sup></italic> embryo displays a fused upper lip and single nostril (black arrow), whereas the EtOH-treated <italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/-</sup></italic> embryo has a fused upper lip and two nostrils (red arrow).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig4-v1.tif"/></fig><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title><italic>Lefty2</italic> Heterozygosity Supresses EtOH-Induced HPE in <italic>Cdon<sup>-/-</sup></italic> Embryos.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Treatment</th><th colspan="4" valign="top">Genotype (# affected/total (%))*</th></tr></thead><tbody><tr><td valign="top"/><td colspan="2" valign="top">Total HPE</td><td colspan="2" valign="top">Single nostril</td></tr><tr><td valign="top"/><td valign="top"><italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/+</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/-</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/+</sup></italic></td><td valign="top"><italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/-</sup></italic></td></tr><tr><td valign="top">Saline</td><td valign="top">1/12 (8.3%)</td><td valign="top">0/10 (0%)</td><td valign="top">0/12 (0%)</td><td valign="top">0/10 (0%)</td></tr><tr><td valign="top">EtOH (3.48 g/kg)</td><td valign="top">33/47 (70.2%)</td><td valign="top">26/48 (54.2%)</td><td valign="top">10/47 (21.3%)</td><td valign="top">3/48 (6.3%)**</td></tr></tbody></table><table-wrap-foot><fn><p>* Crosses between the following genotypes were used to generate the genotypes scored above:</p><p><italic>Cdon<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic> x <italic>Cdon<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic>.</p></fn><fn><p><italic>Cdon<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic> x <italic>Cdo-<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic>.</p><p><italic>Cdon<sup>+/-</sup></italic> x <italic>Cdon<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic>.</p></fn><fn><p><italic>Cdon<sup>+/-</sup></italic> x <italic>Cdo<sup>-/-</sup>;Lefty2<sup>+/-</sup></italic>.</p><p><italic>Cdon<sup>-/-</sup></italic> x <italic>Cdon<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic>.</p></fn><fn><p>No HPE was found in offspring genotypes other than those shown.</p><p>**p=0.04 by Fisher's two-tailed exact test, when compared to EtOH-treated <italic>Cdon<sup>-/-</sup>;Lefty2<sup>+/+</sup></italic> embryos with a single nostril.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-3"><title>EtOH inhibits Activin/Nodal signaling in mEpiSCs</title><p>The APS is a small, transiently existing cell population, making it hard to study directly. Cultured mEpiSCs have transcriptional and functional properties resembling APS cells (<xref ref-type="bibr" rid="bib46">Kojima et al., 2014</xref>; <xref ref-type="bibr" rid="bib98">Tsakiridis et al., 2014</xref>), making them a tractable in vitro surrogate model. mEpiSCs rely on FGF2 and Activin/Nodal signaling for maintenance as self-renewing, pluripotent stem cells (<xref ref-type="bibr" rid="bib14">Brons et al., 2007</xref>; <xref ref-type="bibr" rid="bib99">Vallier et al., 2009</xref>). Activin A and Nodal use the same receptor and signaling mechanism, except that Nodal, but not Activin A, requires the co-receptor TDGF1. Therefore, we evaluated the effects of EtOH on Activin/Nodal signaling in mEpiSCs.</p><p>A direct readout of Nodal signaling activity is receptor-mediated phosphorylation of SMAD2 at its C-terminus (<xref ref-type="bibr" rid="bib82">Robertson, 2014</xref>; <xref ref-type="bibr" rid="bib87">Schier, 2009</xref>; <xref ref-type="bibr" rid="bib88">Shen, 2007</xref>). We assessed C-terminally phosphorylated SMAD2 (p-SMAD2C) and total SMAD2 levels in the mEpiSC line, EpiSC9 (<xref ref-type="bibr" rid="bib72">Najm et al., 2011</xref>), after treatment with EtOH for 6 hr. A relatively short treatment duration was chosen because: 1) the in vivo model is an acute exposure regimen; 2) the window of sensitivity to EtOH-induced HPE is &lt;12 hr; and 3) high EtOH levels last only about 10 hr in pregnant females (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). EtOH dose-dependently diminished p-SMAD2C levels in mEpiSCs, without altering total SMAD2 levels (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Acute EtOH treatment inhibits activin/nodal signaling in mEpiSCs.</title><p>(<bold>A</bold>) Representative western blot of mEpiSCs treated with the indicated doses of EtOH for 6 hr. GAPDH was used as a loading control. (<bold>B</bold>) Densitometric quantification of p-SMAD2C levels, relative to total Smad2; p-JNK1 levels, relative to total JNK1; and p-SMAD2L levels, relative to total SMAD2, with the indicated doses of EtOH. N = 3 experiments with two biological replicates (as shown in (<bold>A</bold>)) in each experiment. (<bold>C</bold>) qRT-PCR analysis of <italic>Nanog</italic>, <italic>Nodal</italic>, <italic>Pou5f1</italic>, and <italic>Sox2</italic> expression in mEpiSCs treated with the indicated doses of EtOH for 6 hr. Expression was normalized to <italic>Gapdh</italic> expression. N = 3 experiments with two biological replicates in each experiment. Values for (<bold>B</bold>) and (<bold>C</bold>) are means ± SEM, *p&lt;0.05, **p&lt;0.01, ***p,0.001 by Student’s t-test.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for quantification of western blot results shown in <xref ref-type="fig" rid="fig5">Figure 5A and B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60351-fig5-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Source data for quantification of qRT-PCR results shown in Figure 5C.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60351-fig5-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Analysis of gene expression in EtOH-treated mEpiSCs.</title><p>qRT-PCR analysis of <italic>Lefty1</italic>, <italic>Lefty2</italic>, <italic>Hoxa1</italic>, <italic>Six1</italic>, and <italic>Gbx2</italic> expression in mEpiSCs treated with the indicated doses of EtOH for 6 hr. Expression was normalized to <italic>Gapdh</italic> expression. N = 3 experiments with two biological replicates in each experiment. Values are means ± SEM, *p&lt;0.05, **p&lt;0.01, ***p,0.001 by Student’s t-test.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Source data for quantification of qRT-PCR results shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title><p><xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60351-fig5-figsupp1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig5-figsupp1-v1.tif"/></fig></fig-group><p>EtOH stimulates activation of the MAP kinase, JNK, in specific cell types (<xref ref-type="bibr" rid="bib63">McAlhany et al., 2000</xref>; <xref ref-type="bibr" rid="bib80">Ren et al., 2017</xref>). SMAD2 is phosphorylated in its linker region by MAP kinases (<xref ref-type="bibr" rid="bib61">Massague, 2003</xref>; <xref ref-type="bibr" rid="bib81">Rezaei et al., 2012</xref>), usually leading to inhibition of SMAD2 function (<xref ref-type="bibr" rid="bib31">Grimm and Gurdon, 2002</xref>; <xref ref-type="bibr" rid="bib50">Kretzschmar et al., 1999</xref>; <xref ref-type="bibr" rid="bib54">Lessard et al., 2018</xref>). We therefore assessed total and phosphorylated (activated) forms of JNK1 MAP kinase in EtOH-treated mEpiSCs. EtOH dose-dependently increased phospho-JNK1 (T183/Y185) levels (p-JNK1; <xref ref-type="fig" rid="fig5">Figure 5A,B</xref>). Consistent with EtOH-induced p-JNK1 activation, phosphorylation of the SMAD2 linker region (p-SMAD2L) also occurred in an EtOH dose-dependent manner, with production of p-JNK1 and p-SMAD2L correlating well (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>).</p><p>Human embryonic stem cells (hESCs) resemble mEpiSCs (<xref ref-type="bibr" rid="bib76">Pauklin and Vallier, 2015</xref>). Treatment of hESC or mEpiSC cultures with the ALK4 inhibitor, SB43152, led to reduction of Activin/Nodal target gene expression and, eventually, induction of early markers of neuroectoderm differentiation (<xref ref-type="bibr" rid="bib15">Chng et al., 2010</xref>; <xref ref-type="bibr" rid="bib55">Li et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Vallier et al., 2009</xref>). These studies generally used time courses of days to weeks, but Vallier et al. assessed expression of five Activin/Nodal target and/or pluripotency-related genes in hESCs treated with SB43152 for 6 hr, the same amount of time we treated mEpiSCs with EtOH. Levels of <italic>Nanog</italic>, <italic>Nodal</italic>, and <italic>LeftyA</italic> mRNA were reduced by SB43152, whereas levels of <italic>Pou5f1</italic> (also called <italic>Oct4</italic>) and <italic>Sox2</italic> underwent little or no change (<xref ref-type="bibr" rid="bib99">Vallier et al., 2009</xref>). We assessed expression of these five genes in mEpiSCs treated with EtOH for 6 hr (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Similar to SB43152-treated hESCs, EtOH-treated mEpiSCs displayed significantly reduced levels of <italic>Nanog</italic> and <italic>Nodal</italic> mRNAs, while <italic>Pou5f1</italic> and <italic>Sox2</italic> mRNA levels were largely unchanged. Expression of the additional SB43152-inhibitable mEpiSC markers <italic>Fgf5</italic> and <italic>T</italic> (<xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref>) were also reduced by EtOH treatment (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). In contrast, EtOH did not alter levels of <italic>Lefty1</italic> or <italic>Lefty2</italic> in mEpiSC cultures (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). As these are known Activin/Nodal target genes, this result might be related to differences in SB43152 vs. EtOH treatment, or differences in half-lives of these mRNAs in human vs. mouse cultures. Therefore, acute EtOH treatment of mEpiSCs resulted in an inhibitory SMAD2 phosphorylation pattern and changes in gene expression similar to those induced by a direct Activin/Nodal pathway inhibitor. Induction of neuroectoderm-specific genes (e.g., <italic>Hoxa1</italic>, <italic>Six1</italic>, and <italic>Gbx2</italic>) was observed in hESCs treated with SB43152 for 2–6 days (<xref ref-type="bibr" rid="bib15">Chng et al., 2010</xref>; <xref ref-type="bibr" rid="bib99">Vallier et al., 2009</xref>). After 6 hr of EtOH treatment, we found a varied response, with <italic>Hoxa1</italic> levels strongly induced, <italic>Six1</italic> expression displaying a biphasic dose-response, and <italic>Gbx2</italic> levels reduced (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>).</p></sec><sec id="s2-4"><title><italic>Cdon</italic> and <italic>Lrp2</italic> genetically interact in mice to generate phenotypes resembling Nodal pathway hypomorphs, and both bind to TDGF1</title><p>Our findings argue that CDON plays an earlier role in development than its known function as a SHH co-receptor. The need for EtOH exposure to reveal this role suggests that CDON’s effects in primitive streak embryos may be redundant with other factors. The HH co-receptors BOC and GAS1 are not likely to be such factors, as <italic>Cdon;Boc;Gas1</italic> triple knockout mice had a phenotype that is close to a complete loss of embryonic HH pathway function, but not Nodal pathway-like phenotypes (<xref ref-type="bibr" rid="bib3">Allen et al., 2011</xref>). LRP2 is an endocytic and auxiliary receptor for multiple morphogenetic ligands and receptors (<xref ref-type="bibr" rid="bib102">Willnow and Christ, 2017</xref>). <italic>Lrp2<sup>-/-</sup></italic> mice have HPE of variable penetrance and severity (<xref ref-type="bibr" rid="bib16">Christ et al., 2012</xref>; <xref ref-type="bibr" rid="bib94">Spoelgen et al., 2005</xref>; <xref ref-type="bibr" rid="bib102">Willnow and Christ, 2017</xref>; <xref ref-type="bibr" rid="bib101">Willnow et al., 2012</xref>). We therefore constructed mice with mutations in <italic>Cdon</italic> and <italic>Lrp2</italic>. Some <italic>Cdon;Lrp2</italic> double mutants at E11.5 had a severe truncation of anterior head and face structures, a phenotype neither single mutant displayed (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Double-mutant embryos studied at several stages displayed a range of phenotypes, including milder craniofacial truncation and strong HPE (<xref ref-type="fig" rid="fig6">Figure 6B,C</xref>). Of 30 <italic>Cdon;Lrp2</italic> double mutants scored between 20 and 37 somites, 24 (80%) had HPE and 6 (20%) displayed anterior truncations. Loss of anterior head structure is a more severe phenotype than that seen even in <italic>Smo</italic> mutants, which lack all HH signaling (<xref ref-type="bibr" rid="bib104">Zhang et al., 2001</xref>). These phenotypes – anterior truncations and HPE – are similar to those observed in mice with partial loss of Nodal pathway function (e.g., hypomorphic <italic>Nodal</italic> and <italic>Tdgf1</italic> mutants, and <italic>Nodal<sup>+/-</sup>;Smad2<sup>+/-</sup></italic> mutants, each have phenotypes that include truncation of anterior head structures and severe HPE) (<xref ref-type="bibr" rid="bib4">Andersson et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Chu et al., 2005</xref>; <xref ref-type="bibr" rid="bib57">Lowe et al., 2001</xref>; <xref ref-type="bibr" rid="bib75">Nomura and Li, 1998</xref>; <xref ref-type="bibr" rid="bib92">Song et al., 1999</xref>). The <italic>Cdon</italic>/<italic>Lrp2</italic> genetic interaction is specific and selective: the <italic>Cdon</italic> paralog <italic>Boc</italic> is not expressed in primitive streak-stage embryos (<xref ref-type="bibr" rid="bib71">Mulieri et al., 2002</xref>; <xref ref-type="bibr" rid="bib104">Zhang et al., 2001</xref>), and <italic>Boc</italic> mutant mice do not synergize with <italic>Lrp2</italic> mutants (unpublished results), nor are they sensitive to EtOH-induced HPE (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>Cdon</italic> and <italic>Lrp2</italic> Interact Genetically to Produce HPE and Anterior Truncations in Mice.</title><p>(<bold>A</bold>) Whole mount E11.5 embryos of the indicated genotype. Note the loss of anterior head structures in the <italic>Cdon<sup>-/-</sup>;Lrp2<sup>-/-</sup></italic> embryo (arrow). (<bold>B</bold>) E18.5 embryos of the indicated genotype in whole mount and alizarin red/alcian blue-stained skeleton preparations. Note the craniofacial truncation in the <italic>Cdon<sup>-/-</sup>;Lrp2<sup>-/-</sup></italic> embryos (arrows). (<bold>C</bold>) Whole mount P0 <italic>Cdon<sup>-/-</sup>;Lrp2<sup>-/-</sup></italic> embryo showing severe HPE.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig6-v1.tif"/></fig><p>CDON is a multifunctional co-receptor and promotes HH-independent signaling when associated with various other receptors and cell adhesion molecules. In addition to binding HH ligands and PTCH1, CDON interacts with and influences signaling by classical cadherins; the Netrin receptor, Neogenin; and the WNT co-receptor, LRP6 (<xref ref-type="bibr" rid="bib9">Bae et al., 2011</xref>; <xref ref-type="bibr" rid="bib8">Bae et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Izzi et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Jeong et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Kang et al., 2003</xref>; <xref ref-type="bibr" rid="bib43">Kang et al., 2004</xref>; <xref ref-type="bibr" rid="bib58">Lu and Krauss, 2010</xref>; <xref ref-type="bibr" rid="bib97">Tenzen et al., 2006</xref>). We hypothesized that CDON might work similarly in Nodal signaling. To address this possibility, we assessed whether CDON binds to Nodal receptor components. A secreted CDON ectodomain fused in-frame at its carboxy terminus with the IgG Fc region (CDON-Fc) was expressed in HEK293T cells with individual ectodomains of the Nodal receptor (ActRIIA, ActRIIB, ALK4, and TDGF1) fused in-frame at their carboxy termini with alkaline phosphatase (AP). As positive and negative controls, SHH-N-AP and CD164-AP were used, respectively (SHH-N is the active portion of SHH, CD164 is a cell surface sialomucin) (<xref ref-type="bibr" rid="bib41">Kang et al., 2002</xref>; <xref ref-type="bibr" rid="bib97">Tenzen et al., 2006</xref>). The use of secreted ectodomains reduces the possibility that unknown, cell surface-bound factors promote binding or contribute directly to the complex. Conditioned medium was collected, and equivalent amounts of AP fusion proteins from conditioned media were pulled down and blotted for captured CDON-Fc. Conversely, equivalent levels of Fc were pulled down, and associated AP activity was quantified. Similar results were obtained in each pull-down: CDON-Fc interacted efficiently with TDGF1-AP, similar to the interaction between CDON-Fc and SHH-N-AP (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>). CDON-Fc did not bind to the negative control CD164-AP, and it interacted only weakly with the AP-tagged versions of ALK4, ActRIIA, and ActRIIB (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>CDON and LRP2 Bind to TDGF1.</title><p>(<bold>A</bold>) The indicated AP-tagged proteins were co-expressed with CDON-Fc, and equivalent amounts of AP proteins in conditioned medium (CM) were pulled down. Levels of CDON-Fc in CM and in the pull down were detected by western blot. (<bold>B</bold>) CDON-Fc was pulled down from CM derived from transfections as in (<bold>A</bold>), the amount of CDON-Fc from various CM normalized, and associated AP enzyme activity quantified, N = ≥4 for (<bold>A</bold>) and (<bold>B</bold>). (<bold>C</bold>) Schematic of full length LRP2 and recombinant mini-receptor variants used. Each mini-receptor spans one of the four repetitive modules of the extracellular receptor domain and was expressed either as soluble ectodomain fragments fused to IgG Fc (designated sR1- sR4) or as a membrane-bound mini-receptor fused to the authentic transmembrane and intracellular domains of LRP2 (designated R1- R4). Soluble ectodomain fragments sR1 – sR4 were studied in panel (<bold>D</bold>), whereas mini-receptors R1 – R4 were used in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref> . Amino acid numbers next to the full-length receptor polypeptide indicate the extent of individual receptor domains. (<bold>D</bold>) The indicated Fc-tagged proteins were pulled down from CM derived from transfections as in (<bold>A</bold>), the amount of Fc-tagged protein from various CM normalized, and associated AP enzyme activity quantified, N = 3. Values for (<bold>B</bold>) and (<bold>D</bold>) are means ± SEM, *p&lt;0.05, **p&lt;0.01 by Student’s t-test.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Source data for quantification of AP activity in CDON-Fc pulldown experiments shown in <xref ref-type="fig" rid="fig7">Figure 7B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60351-fig7-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Source data for quantification of AP activity in CDON-Fc and soluble LRP2 minireceptor-Fc pulldown experiments shown in <xref ref-type="fig" rid="fig7">Figure 7D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60351-fig7-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>HEK293 cell transfectants expressing the indicated LRP2 mini-receptor were incubated with GST-SHH-N, and cell lysates immunoprecipitated with antibody to LRP2 and blotted with antibodies to LRP2 and GST.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60351-fig7-figsupp1-v1.tif"/></fig></fig-group><p>As CDON and LRP2 interacted genetically to produce Nodal hypomorph-like phenotypes, we asked whether LRP2, like CDON, binds to TDGF1. The extracellular region of LRP2 harbors four repetitive modules, each comprising a cluster of complement-type repeats followed by EGF-type repeats and β-propellers. Each module is likely capable of independently binding ligands, as shown for the related receptor, LRP1 (<xref ref-type="bibr" rid="bib24">Croy et al., 2003</xref>). LRP2 is a huge polypeptide of 4660 amino acids, making it difficult to express in vitro. Therefore, we constructed a series of soluble ‘mini-receptors’ (designated sR1, sR2, sR3, and sR4) spanning virtually the entire ectodomain in four non-overlapping pieces, each fused in-frame at their carboxy termini to the IgG Fc region (see <xref ref-type="fig" rid="fig7">Figure 7C</xref>). Each soluble ectodomain segment and TDGF1-AP were expressed in HEK293T cells and assessed for their ability to bind to each other. LRP2 binds SHH-N (<xref ref-type="bibr" rid="bib16">Christ et al., 2012</xref>; <xref ref-type="bibr" rid="bib64">McCarthy et al., 2002</xref>), so this ligand was used again as a positive control, with CD164-AP serving as a presumptive negative control. Each soluble LRP2 mini-receptor ectodomain (i.e., sR1 to sR4) pulled down SHH-N-AP, revealing that LRP2 harbors multiple SHH-N binding sites (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). These results were confirmed by expressing each ectodomain segment joined with the native LRP2 transmembrane and cytoplasmic domains (mini-receptors R1, R2, R3, and R4; <xref ref-type="fig" rid="fig7">Figure 7C</xref>) in NIH3T3 cells. These cultures were incubated with recombinant SHH-N-GST fusion proteins for 2 hr, followed by immunoprecipitation with anti-LRP2 antibody recognizing all mini-receptors and western blotting with antibodies to LRP2 or GST. Again, all four mini-receptors pulled down SHH-N, whereas no pulldown of SHH-N was seen in control transfectants lacking LRP2 mini-receptors (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Finally, we assessed LRP2 binding to TDGF1 with the soluble ectodomain binding assay. Similar to its multivalent interaction with SHH-N, the soluble LRP2 ectodomain segments sR3 and sR4 pulled down TDGF1-AP (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). Soluble LRP2 ectodomain segments sR1 and sR2 also pulled down TDGF1-AP, but greater variability in the interaction was observed, leading to p&gt;0.05 (p=0.14 and p=0.06, respectively). The efficiency of LRP2 mini-receptor ectodomains to bind SHH-N-AP and TDGF1-AP was similar to that of CDON-Fc (<xref ref-type="fig" rid="fig7">Figure 7D</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>HPE is a common developmental disorder, but its etiology remains poorly understood. Mutations in the Nodal, HH, and FGF pathways are associated with HPE (<xref ref-type="bibr" rid="bib74">NISC Comparative Sequencing Program et al., 2018</xref>), but these alone are insufficient to drive aberrant development. Identifying and understanding the critical phenotypic modifiers of such mutations is important but still in its infancy. Many birth defects are thought to be caused by poorly defined interactions between genetic and environmental risk factors, but the mechanistic bases of these interactions are largely unknown (<xref ref-type="bibr" rid="bib49">Krauss and Hong, 2016</xref>). <italic>Cdon</italic> mutation and fetal alcohol are each implicated in human HPE (<xref ref-type="bibr" rid="bib1">Abe et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Bae et al., 2011</xref>; <xref ref-type="bibr" rid="bib19">Cohen and Shiota, 2002</xref>; <xref ref-type="bibr" rid="bib23">Croen et al., 2000</xref>; <xref ref-type="bibr" rid="bib74">NISC Comparative Sequencing Program et al., 2018</xref>), though neither may be sufficient. The <italic>Cdon</italic> mutation plus fetal alcohol model is noteworthy for its specificity and fidelity to many aspects of human HPE (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). Therefore, illumination of how loss of <italic>Cdon</italic> interacts with in utero EtOH exposure provides insight into mechanisms of HPE and how fetal alcohol functions as a teratogen.</p><p>The Nodal pathway is developmentally upstream from the HH pathway in patterning the rostroventral midline. While CDON is clearly a component of the HH pathway, it regulates signaling within several additional pathways as well (<xref ref-type="bibr" rid="bib9">Bae et al., 2011</xref>; <xref ref-type="bibr" rid="bib8">Bae et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Izzi et al., 2011</xref>; <xref ref-type="bibr" rid="bib39">Jeong et al., 2014</xref>; <xref ref-type="bibr" rid="bib42">Kang et al., 2003</xref>; <xref ref-type="bibr" rid="bib43">Kang et al., 2004</xref>; <xref ref-type="bibr" rid="bib58">Lu and Krauss, 2010</xref>; <xref ref-type="bibr" rid="bib97">Tenzen et al., 2006</xref>). Multiple lines of evidence presented here argue that CDON also regulates Nodal signaling and that the Nodal pathway is a major point of synergistic interaction between mutation of <italic>Cdon</italic> and fetal EtOH exposure. The evidence includes: (1) EtOH-treated <italic>Cdon<sup>-/-</sup></italic> embryos display defects in expression of Nodal target genes in the APS (including <italic>Gsc</italic>, <italic>Foxa2</italic>, and <italic>Lefty2</italic>), whereas EtOH treatment or <italic>Cdon</italic> mutation alone do not (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>; this study); (2) the window of sensitivity to EtOH-induced HPE is very narrow and closed by E7.5, a time reported to be prior to SHH expression and function in prechordal plate-mediated rostroventral midline patterning; (3) EtOH itself is the likely HPE-inducing teratogen and peak circulating EtOH levels coincide with Nodal signaling in the APS; (4) <italic>Cdon</italic> interacts genetically with the critical Nodal pathway factors <italic>Tdgf1</italic> and <italic>Lefty2</italic> in EtOH-induced HPE; (5) acute EtOH treatment dose-dependently diminishes p-SMAD2C and elevates p-SMAD2L levels, and inhibits Activin/Nodal-dependent gene expression, in mEpiSCs; (6) <italic>Cdon;Lrp2</italic> double mutants display phenotypes similar to mice with hypomorphic Nodal pathway mutations, including anterior truncations, a phenotype not seen in mice lacking all HH signaling; and (7) CDON and LRP2 both bind efficiently to TDGF1, an essential component of the Nodal receptor. We note that although EtOH inhibited p-SMAD2C production in mEpiSCs, and diminished expression of Nodal target genes in both mEpiSCs and <italic>Cdon<sup>-/-</sup></italic> embryos, we have not yet demonstrated that EtOH inhibits p-SMAD2C production in embryos; additional work is therefore required to show the mechanisms in vitro and in vivo operate at the same level. Similarly, analysis of Nodal signaling in <italic>Cdon;Lrp2</italic> double mutant embryos requires study.</p><p>Together our findings are consistent with the following model: CDON and LRP2 function with overlapping or compensatory roles to regulate Nodal pathway signaling in the APS during induction of the PCP. Brief exposure of <italic>Cdon<sup>-/-</sup></italic> embryos to EtOH during this period transiently and partially inhibits Nodal pathway activity. While all the mice successfully gastrulate, they emerge from this period predisposed towards development of HPE in a stochastic manner. If HH signaling strength fails to reach a required threshold early during rostroventral midline patterning, at the PCP stage, the outcome is alobar HPE and cyclopia; if it occurs at later stages of development, the outcomes are progressively less severe. Aspects of the model will require additional experimentation, but it is logically consistent with the synergistic effects of fetal alcohol and <italic>Cdon</italic> mutation within a narrow window of sensitivity, and also with the ‘mutation plus modifier’ view of human HPE. Our findings do not exclude that EtOH may also target HH signaling in <italic>Cdon<sup>-/-</sup></italic> mice, but they are consistent with Nodal signaling being a major target of EtOH in HPE.</p><p>The specific mechanisms whereby acute EtOH treatment reduces expression of Nodal target genes in the APS of <italic>Cdon<sup>-/-</sup></italic> mice and diminishes Activin/Nodal signaling in mEpiSCs are not known. EtOH itself, rather than consequences of its oxidative metabolism, is very likely the HPE-inducing teratogen (<xref ref-type="bibr" rid="bib35">Hong and Krauss, 2017</xref>). An alternative mechanism to metabolism-based toxicity is that EtOH itself functions to perturb cell membranes via its hydrophobicity (<xref ref-type="bibr" rid="bib59">Lyon et al., 1981</xref>; <xref ref-type="bibr" rid="bib66">McKarns et al., 1997</xref>). One possibility is that EtOH’s hydrophobic nature perturbs trafficking of Nodal receptor components or their stable assembly at the cell surface. TDGF1 is a GPI-linked protein, so might be especially vulnerable to hydrophobic membrane perturbation. However, exogenously provided Activin A is the major activator of SMAD2 in cultured mEpiSCs, and Activin does not require TDGF1 to signal through ActRII/ALK4. EtOH reduces p-SMAD2C levels in these cultures, so TDGF1 may not be a direct critical target of EtOH. Nevertheless, mEpiSCs endogenously express Nodal (<xref ref-type="bibr" rid="bib46">Kojima et al., 2014</xref>), which does require TDGF1, and its contribution to SMAD2 signaling in these cultures is not fully clear. Additionally, EtOH activates JNK1 in mEpiSCs, with a corresponding increase in p-SMAD2L levels. Phosphorylation of SMAD2 by MAP kinases is generally inhibitory to SMAD2 activity, independent of p-SMAD2C phosphorylation status (<xref ref-type="bibr" rid="bib61">Massague, 2003</xref>; <xref ref-type="bibr" rid="bib81">Rezaei et al., 2012</xref>), so EtOH appears to promote or inhibit multiple signals that converge on SMAD2 phosphorylation.</p><p>CDON regulates several signaling pathways, but it has not previously been implicated in Nodal signaling. How CDON functions to regulate Nodal signaling is of obvious interest. <italic>Cdon;Lrp2</italic> double mutant mice display phenotypes that resemble Nodal pathway hypomorphs, and CDON and LRP2 each bind to TDGF1. Therefore, as with the effects of EtOH, TDGF1 is a possible point of regulation. One potential mechanism is that CDON and LRP2 might function as components of a larger Nodal receptor complex, contributing via interaction with TDGF1. Alternatively, they may work with TDGF1 in processing and trafficking of Nodal or other receptor components, or play a role in processing and trafficking of TDGF1 itself (<xref ref-type="bibr" rid="bib21">Constam, 2009</xref>). There is evidence in other systems that CDON and LRP2 can act in such a manner. LRP2 is best understood as an endocytic receptor that controls internalization and intracellular trafficking of both soluble and membrane-bound proteins, including PTCH1, the Na<sup>+</sup>/H<sup>+</sup> exchanger NHE3, and the intrinsic factor receptor, Cubilin (<xref ref-type="bibr" rid="bib102">Willnow and Christ, 2017</xref>). Furthermore, CDON regulates subcellular localization of N-cadherin during neural crest migration in zebrafish (<xref ref-type="bibr" rid="bib79">Powell et al., 2015</xref>). Similarly, the <italic>Drosophila</italic> orthologs of CDON act not only as co-receptors for HH, but in trafficking of the primary HH receptor, PTC (<xref ref-type="bibr" rid="bib107">Zheng et al., 2010</xref>). Another possibility is in regulation of cell-cell contact and adhesion. CDON is localized to sites of cell-cell contact and functions with N-cadherin in cell adhesion-dependent signaling (<xref ref-type="bibr" rid="bib42">Kang et al., 2003</xref>; <xref ref-type="bibr" rid="bib58">Lu and Krauss, 2010</xref>). In zebrafish, a positive feedback loop exists between Nodal signaling, E-cadherin expression, and duration of cell-cell contact, that directs PCP specification at the expense of endoderm specification (<xref ref-type="bibr" rid="bib10">Barone et al., 2017</xref>). It is conceivable that CDON could play a role in adhesion-mediated, higher order regulatory events like this as well. These varied potential mechanisms are not mutually exclusive.</p><p>Our findings offer insight into how <italic>Cdon</italic> mutation synergizes with fetal alcohol in mice to produce a wide spectrum of HPE phenotypes, closely resembling the complex etiology and variable outcomes seen in humans at the population level. A combination of approaches, including window of sensitivity studies, genetic interactions in mice, and in vitro analyses revealed that, unexpectedly, a major point of synergy is at the level of Nodal signaling. These findings illuminate gene-environment interactions in the causation of a common birth defect, expand understanding of alcohol teratogenesis, and serve as a conceptual framework for additional developmental anomalies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td>Cdon<sup>-</sup></td><td>MGI</td><td>MGI:1926387</td><td> </td></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td>Cripto<sup>-</sup></td><td>MGI</td><td>MGI:98658</td><td/></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td>Lefty2<sup>-</sup></td><td>MGI</td><td>MGI:2443573</td><td/></tr><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td>Lrp2<sup>-</sup></td><td>MGI</td><td>MGI:95794</td><td/></tr><tr><td>Cell line (Human)</td><td>HEK293T</td><td>ATCC</td><td> </td><td/></tr><tr><td>Cell line (<italic>Mus musculus</italic>)</td><td>EpiSC9</td><td><xref ref-type="bibr" rid="bib72">Najm et al., 2011</xref></td><td> </td><td><xref ref-type="bibr" rid="bib37">Huang et al., 2017</xref> <break/><xref ref-type="bibr" rid="bib46">Kojima et al., 2014</xref></td></tr><tr><td valign="top">Antibody</td><td>anti-Smad2 (Rabbit mAB)</td><td>Cell Signaling</td><td>#5339</td><td>WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td>anti-phospho-Smad2C (Rabbit mAB)</td><td>Cell Signaling</td><td>#3108</td><td>WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td>anti-phospho-Smad2L (Rabbit mAB)</td><td>Cell Signaling</td><td>#3104</td><td>WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td>anti-JNK (Rabbit polyclonal)</td><td>Cell Signaling</td><td>#9252</td><td>WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td>anti-phospho-JNK (Rabbit polyclonal)</td><td>Cell Signaling</td><td>#9251</td><td>WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td>anti-Gapdh (Mouse mAB)</td><td>Cell Signaling</td><td>#97166</td><td>WB (1:5000)</td></tr><tr><td>Antibody</td><td>anti-DIG AP conjugated</td><td>Roche</td><td>11093274910</td><td>WM in situ (1:2000)</td></tr><tr><td>Antibody</td><td>anti-LRP2 (Goat)</td><td><xref ref-type="bibr" rid="bib100">Willnow et al., 1996</xref></td><td/><td>WB (1:1000)</td></tr><tr><td>Recombinant DNA reagent</td><td>SHH-N-AP (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>CD164-AP (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>ActRIIA-AP (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>ALK4-AP (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>Cripto-AP (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>LRP2 sR1-Fc (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>LRP2 sR2-Fc (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>LRP2 sR3-Fc (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>LRP2 sR4-Fc (plasmid)</td><td>This paper</td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>Cdon-Fc (plasmid)</td><td><xref ref-type="bibr" rid="bib42">Kang et al., 2003</xref></td><td> </td><td/></tr><tr><td>Peptide, recombinant protein</td><td>Human Plasma Fibronectin purified protein</td><td>MilliporeSigma</td><td>FC010</td><td>10 μg/ml/cm<sup>2</sup></td></tr><tr><td>Peptide, recombinant protein</td><td>Activin A</td><td>R and D Systems</td><td>338-AC</td><td>20 ng/ml</td></tr><tr><td>Peptide, recombinant protein</td><td>FGF2</td><td>R and D Systems</td><td> 234-FSE</td><td>12 ng/ml</td></tr><tr><td>Peptide, recombinant protein</td><td>IgG Fc (human)</td><td>Jackson Laboratories</td><td>009-000-008</td><td> </td></tr><tr><td>Peptide, recombinant protein</td><td>Protein G-agarose beads</td><td>Roche</td><td>11243233001</td><td/></tr><tr><td>Peptide, recombinant protein</td><td>Anti-AP-conjugated agarose beads</td><td>Sigma</td><td>A2080</td><td/></tr><tr><td>Commercial assay or kit</td><td>AP yellow liquid substrate</td><td>Sigma</td><td>P7998</td><td/></tr><tr><td>Commercial assay or kit</td><td>BM Purple</td><td>Roche</td><td>11442074001 <break/></td><td/></tr><tr><td>Commercial assay or kit</td><td>DIG-labeling kit</td><td>Roche</td><td>11277073910</td><td/></tr><tr><td>Commercial assay or kit</td><td>Effectene transfection reagent</td><td>Qiagen</td><td> 301425</td><td> </td></tr><tr><td>Commercial assay or kit</td><td>RNA easy mini kit</td><td>Qiagen</td><td> 74104</td><td> </td></tr><tr><td>Commercial assay or kit</td><td>Superscript III First strand synthesis system</td><td>Invitrogen</td><td>18080051 <break/></td><td/></tr><tr><td>Commercial assay or kit</td><td>iQ SyBR Green Supermix</td><td>BioRad</td><td>1708882</td><td/></tr><tr><td>Software, algorithm</td><td>Prism 8</td><td>GraphPad</td><td>Prism 8 for MacOS ver 8.4.3</td><td/></tr><tr><td>Sequence-based reagent</td><td>GAPDH_F</td><td>Invitrogen <break/><xref ref-type="bibr" rid="bib26">Dong et al., 2008</xref></td><td>PCR primers</td><td><named-content content-type="sequence">AACGACCCCTTCATTGAC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>GAPDH_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib26">Dong et al., 2008</xref></td><td>PCR primers</td><td><named-content content-type="sequence">TCCACGACATACTCAGCAC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Fgf5_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">GCTGTGTCTCAGGGGATTGT</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Fgf5_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CACTCTCGGCCTGTCTTTTC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Gbx2_F</td><td>Invitrogen; <break/>Harvard Primer Bank 133892275c2</td><td>PCR primers</td><td><named-content content-type="sequence">GCAACTTCGACAAAGCCGAG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Gbx2_R</td><td>Invitrogen; <break/>Harvard Primer Bank 133892275c2</td><td>PCR primers</td><td><named-content content-type="sequence">CCTTGCCCTTCGGGTCATC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Hoxa1_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib62">Matt et al., 2005</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CGCACAATGTTCTGATGTCC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Hoxa1_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib62">Matt et al., 2005</xref></td><td>PCR primers</td><td><named-content content-type="sequence">TGCAAGCTTCATGACAGAGG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Lefty1_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">AACCGCACTGCCCTTAT</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Lefty1_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CGCGAAACGAACCAACTTGT</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Lefty2_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CAGCCAGAATTTTCGAGAGGT</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Lefty2_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CAGTGCGATTGGAGCCATC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Nanog_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib15">Chng et al., 2010</xref></td><td>PCR primers</td><td><named-content content-type="sequence">GGACTTTCTGCAGCCTTACG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Nanog_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib15">Chng et al., 2010</xref></td><td>PCR primers</td><td><named-content content-type="sequence">GCTTCCAAATTCACCTCCAA</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Nodal_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CCTGGAGCGCATTTGGATG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Nodal_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">ACTTTCTGCTCGACTGGACA</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Pou5f1_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">AGTTGGCGTGGAGACTTTGC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Pou5f1_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CAGGGCTTTCATGTCCTGG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Six1_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib15">Chng et al., 2010</xref></td><td>PCR primers</td><td><named-content content-type="sequence">TTAAGAACCGGAGGCAAAGA</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Six1_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib15">Chng et al., 2010</xref></td><td>PCR primers</td><td><named-content content-type="sequence">GGGGGTGAGAACTCCTCTTC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Sox2_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">GCGGAGTGGAAACTTTTGTCC</named-content></td></tr><tr><td>Sequence-based reagent</td><td>Sox2_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CGGGAAGCGTGTACTTATCCTT</named-content></td></tr><tr><td>Sequence-based reagent</td><td>T_F</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">CTCGGATTCACATCGTGAGAG</named-content></td></tr><tr><td>Sequence-based reagent</td><td>T_R</td><td>Invitrogen; <break/><xref ref-type="bibr" rid="bib56">Liu et al., 2018</xref></td><td>PCR primers</td><td><named-content content-type="sequence">AAGGCTTTAGCAAATGGGTTGTA</named-content></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>All animal procedures were conducted in accordance with institutional guidelines for the care and use of laboratory animals as approved by the Institutional Animal Care and Use Committee (IACUC) of the Icahn School of Medicine at Mount Sinai and according to Max-Delbruck-Center guidelines following approval by local authorities (X9007/17). B6.129P2-<italic>Lefty2<sup>tm1Hmd</sup></italic> mice were provided by Hiroshi Hamada. <italic>Tdgf1</italic> mutant mice (<italic>Cripto-LacZ</italic> mice) were provided by Michael Shen. Both strains were transferred onto the 129S6/SvEvTac (129S6) background with the Taconic Speed Congenic Program, by backcrossing and mapping with the 1450 SNP array. Mice used for these experiments were estimated to be over 98% 129S6/SvEvTac background. These lines were crossed with <italic>Cdon<sup>+/tm1Rsk</sup></italic> (<italic>Cdon<sup>+/-</sup></italic>) mice on the 129S6 background (<xref ref-type="bibr" rid="bib20">Cole and Krauss, 2003</xref>; <xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>) to generate 129S6.<italic>Cdon<sup>+/-</sup>;Lefty2<sup>+/-</sup></italic> and 129S6.<italic>Cdon<sup>+/-</sup>Tdgf1<sup>+/-</sup></italic> double mutant mice. Because <italic>Cdon</italic> and <italic>Tdgf1</italic> are both located on chromosome 9, <italic>Cdon<sup>+/-</sup>;Tdgf1<sup>+/-</sup></italic> mice were crossed with wild type mice and offspring screened for those that carried a recombinant chromosome 9 carrying both <italic>Cdon</italic> and <italic>Tdgf1</italic> mutant alleles. Offspring of intercrosses of these mice were further crossed (see <xref ref-type="table" rid="table2">Tables 2</xref> and <xref ref-type="table" rid="table3">3</xref> for details) and pregnant females treated with EtOH or saline as a control (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). Briefly, two- to three-month old mice were mated for one hour in the dark and plugged females were collected. The time of the plug was designated as embryonic day (E) 0.0. Pregnant female mice were injected intraperitoneally twice with 15 μl per g body weight of solution of 30% EtOH in saline (3.48 g/kg) at E7.0 and again 4 hr later. For window-of-sensitivity experiments, pregnant females were treated similarly, except the initial dose was given at E7.25 or E7.5. For studies involving <italic>Cdon;Tdgf1</italic> mutants, a lower dose of ethanol (25% EtOH in saline, 2.9 g/kg) was used. Saline injections were used as controls throughout.</p><p>Mice with targeted gene disruption of <italic>Lrp2</italic> (<italic>Lrp2<sup>tm1Her</sup></italic>) have been described (<xref ref-type="bibr" rid="bib100">Willnow et al., 1996</xref>). <italic>Lrp2<sup>+/tm1Her</sup></italic> (<italic>Lrp2<sup>+/-</sup></italic>) mice were kept on the C57BL/6N genetic background and crossed with <italic>Cdon<sup>+/-</sup></italic> mice on the C57BL/6N genetic background. Offspring were further intercrossed, and <italic>Lrp2<sup>+/-</sup>;Cdon<sup>+/-</sup></italic> mice were subjected to timed mating to collect embryos at the depicted embryonic day. Neither <italic>Cdon<sup>-/-</sup></italic> mice nor <italic>Lrp2<sup>-/-</sup></italic> mice on the C57BL/6N display anterior truncation phenotypes.</p></sec><sec id="s4-2"><title>Whole mount in situ hybridization</title><p>Whole mount RNA in situ hybridization was performed according to standard protocols (<xref ref-type="bibr" rid="bib33">Hong and Krauss, 2012</xref>). Briefly, embryos were dissected out and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS), dehydrated through a graded methanol series, and stored at −20°C. Rehydrated embryos were treated with 10 μg/ml proteinase K (Qiagen) in PBS, 0.1% Tween-20 (PBST) according to stage. Embryos were rinsed with PBST, post-fixed and hybridized with digoxygenin (DIG)-labeled probe in hybridization mix (50% formamide, 1.3x SSC pH 5.0, 5 mM EDTA, 50 μg/ml yeast tRNA, 100 μg/ml heparin, 0.2% Tween-20, and 0.5% CHAPS) overnight at 65°C. They were washed, blocked with 2% Roche blocking reagent, 20% heat-inactivated lamb serum in Tris-buffered saline with 0.1% Tween-20 (TBST) and incubated with alkaline phosphate-conjugated anti-DIG antibody (1:2000, Roche) in blocking buffer overnight at 4°C. After washing with TBST and NTMT (100 mM NaCl, 100 mM Tris pH9.5, 50 mM MgCl<sub>2</sub>, and 0.1% Tween-20), embryos were stained with BM Purple AP substrate (Roche) in the dark. Stained embryos were cleared in 80% glycerol and photographed with a Jenoptik ProgRes C3 camera attached to Nikon SMZ 1500 stereomicroscope. Captured images were assembled by Helicon Focus software (Helicon Soft).</p></sec><sec id="s4-3"><title>Mouse epiblast stem cell culture and western blot and qRT-PCR analysis</title><p>Mouse epiblast stem cells (EpiSC9 cells) were obtained from Jianlong Wang, authenticated by robust expression of pluripotency markers, and confirmed to be negative for mycoplasma infection. EpiSC9 cells were cultured as described (<xref ref-type="bibr" rid="bib37">Huang et al., 2017</xref>). Briefly, cells were cultured on 0.1% fibronectin-coated plates (MilliporeSigma, 10 μg/ml/cm<sup>2</sup>) in N2B27 media supplemented with 20 ng/ml Activin A (R and D Systems) and 12 ng/ml Fgf2 (R and D Systems). Media were changed daily. EpiScs were treated with EtOH for six hours in fresh EpiSC media with supplements. For protein analysis, cells were harvested with RIPA buffer plus protease inhibitor (Sigma) and phosphatase inhibitor (Sigma). Western blotting was as described (<xref ref-type="bibr" rid="bib8">Bae et al., 2009</xref>). Images were scanned and quantified using ImageJ software. Statistical significance was calculated using Student’s t-test and a cutoff of p&lt;0.05. Primary antibodies used for western blot: SMAD2 (Cell Signaling #5339), p-SMAD2C (Cell Signaling #3108), p-SMAD2L (Cell Signaling #3104), JNK (Cell Signaling #9252), p-JNK (Cell Signaling #9251), and GAPDH (Cell Signaling #97166). For mRNA analysis, total RNA was extracted from EpiSCs using the RNAeasy kit (Quiagen). Reverse transcription and cDNA production were performed with Superscript III first strand synthesis system (Invitrogen). qPCR was performed using iQ SyBR green supermix (BioRad) on an iCycler iQ5 (BioRad). Gene expression levels were normalized to <italic>Gapdh</italic>.</p></sec><sec id="s4-4"><title>Protein-protein interactions</title><p>Expression vectors encoding soluble, tagged forms of CDON, SHH-N, CD164, ActRIIA, ActRIIB, ALK4, TDGF1, and LRP2, and LRP2 mini-receptors that encoded the LRP2 transmembrane and intracellular domains, were constructed by standard methods; details are available on request. HEK293T cells were obtained from ATCC, confirmed to be negative for mycoplasma infection, and cultured in DMEM with 10% FBS and 1x Penicillin/Streptomycin. HEK293T cells in 10 cm dishes were transfected with a total of either 2 or 3 μg of plasmid vectors using Effectene reagent (Qiagen). Media were changed to 2% FBS two days after transfection. Conditioned media were harvested five days afterwards. Soluble fusion proteins in conditioned media were quantified by dot blotting with human IgG Fc protein (Jackson ImmunoResearch Laboratories) as a standard, and by alkaline phosphatase (AP) enzyme activity using AP yellow liquid substrate (Sigma). For analysis of CDON-Fc interactions with soluble AP-tagged proteins, the factors were coexpressed in HEK293T cells. For Fc pull down and AP activity assays with CDON-Fc, soluble fusion proteins were incubated with protein G agarose beads (Roche) for 2 hr at 4°C. For analysis of soluble LRP2-Fc mini-receptors interactions with soluble AP-tagged proteins, LRP2 sR1-sR4 and the AP-tagged counterparts were generated separately in individual transfections and CM mixed together. Pull down complexes were washed five times with ice-cold HNTG buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol). Endogenous AP was inactivated by heat inactivation. AP activity in pull-down complexes was measured using AP yellow liquid substrate (Sigma). For AP pull down followed by western blot analysis, soluble fusion proteins were incubated with anti-AP conjugated agarose beads (Sigma) overnight at 4°C. Pull-down complexes were washed five times with HNTG buffer, eluted from the beads by boiling, and separated by SDS-PAGE. Antibodies used for western blot were HRP conjugated with goat anti-human Fc.</p><p>To test SHH-N interaction with membrane-bound LRP2 mini-receptors, NIH3T3 cells were transfected with the four individual LRP2 mini-receptors encoding transmembrane and intracellular domains and incubated with 20 μg/ml GST-SHH-N in the medium for two hours. Cell lysates were immunoprecipitated with polyclonal LRP2 antibody directed against full-length LRP2, and subjected to western blot analysis with anti-LRP2 and anti-GST antibodies.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Horoshi Hamada for providing <italic>Lefty2</italic> mutant mice and reagents; Michael Shen for providing <italic>Tdgf1</italic> mutant mice and reagents; Zoe Fresquez and Marysia-Kolbe Rieder for technical support; Xin Huang and Jianlong Wang for EpiSC9 cells and advice; Nadeera Wickramasinghe and Nicole Dubois for generous support with cell culture; Steve Farber and Phil Soriano for helpful discussions, and members of the Krauss lab for reading the manuscript.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing - original draft, Project administration</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal procedures were conducted in accordance with institutional guidelines for the care and use of laboratory animals as approved by the Institutional Animal Care and Use Committee (IACUC) of the Icahn School of Medicine at Mount Sinai (protocol number 14-0191) and according to Max-Delbruck-Center guidelines following approval by local authorities (protocol number X9007/17).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-60351-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname> <given-names>Y</given-names></name><name><surname>Kruszka</surname> <given-names>P</given-names></name><name><surname>Martinez</surname> <given-names>AF</given-names></name><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Shiota</surname> <given-names>K</given-names></name><name><surname>Yamada</surname> <given-names>S</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Clinical and demographic evaluation of a holoprosencephaly cohort from the kyoto collection of human embryos</article-title><source>The Anatomical Record</source><volume>301</volume><fpage>973</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.1002/ar.23791</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Addissie</surname> <given-names>YA</given-names></name><name><surname>Kruszka</surname> <given-names>P</given-names></name><name><surname>Troia</surname> <given-names>A</given-names></name><name><surname>Wong</surname> <given-names>ZC</given-names></name><name><surname>Everson</surname> <given-names>JL</given-names></name><name><surname>Kozel</surname> <given-names>BA</given-names></name><name><surname>Lipinski</surname> <given-names>RJ</given-names></name><name><surname>Malecki</surname> <given-names>KMC</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prenatal exposure to pesticides and risk for holoprosencephaly: a case-control study</article-title><source>Environmental Health</source><volume>19</volume><elocation-id>65</elocation-id><pub-id pub-id-type="doi">10.1186/s12940-020-00611-z</pub-id><pub-id pub-id-type="pmid">32513280</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>BL</given-names></name><name><surname>Song</surname> <given-names>JY</given-names></name><name><surname>Izzi</surname> <given-names>L</given-names></name><name><surname>Althaus</surname> <given-names>IW</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Charron</surname> <given-names>F</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Overlapping roles and collective requirement for the coreceptors GAS1, CDO, and BOC in SHH pathway function</article-title><source>Developmental Cell</source><volume>20</volume><fpage>775</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.04.018</pub-id><pub-id pub-id-type="pmid">21664576</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>O</given-names></name><name><surname>Reissmann</surname> <given-names>E</given-names></name><name><surname>Jörnvall</surname> <given-names>H</given-names></name><name><surname>Ibáñez</surname> <given-names>CF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Synergistic interaction between Gdf1 and nodal during anterior Axis development</article-title><source>Developmental Biology</source><volume>293</volume><fpage>370</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.02.002</pub-id><pub-id pub-id-type="pmid">16564040</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ang</surname> <given-names>SL</given-names></name><name><surname>Rossant</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>HNF-3β is essential for node and notochord formation in mouse development</article-title><source>Cell</source><volume>78</volume><fpage>561</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(94)90522-3</pub-id><pub-id pub-id-type="pmid">8069909</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoto</surname> <given-names>K</given-names></name><name><surname>Shikata</surname> <given-names>Y</given-names></name><name><surname>Higashiyama</surname> <given-names>D</given-names></name><name><surname>Shiota</surname> <given-names>K</given-names></name><name><surname>Motoyama</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fetal ethanol exposure activates protein kinase A and impairs Shh expression in prechordal mesendoderm cells in the pathogenesis of holoprosencephaly</article-title><source>Birth Defects Research Part A: Clinical and Molecular Teratology</source><volume>82</volume><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1002/bdra.20447</pub-id><pub-id pub-id-type="pmid">18338389</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoto</surname> <given-names>K</given-names></name><name><surname>Shikata</surname> <given-names>Y</given-names></name><name><surname>Imai</surname> <given-names>H</given-names></name><name><surname>Matsumaru</surname> <given-names>D</given-names></name><name><surname>Tokunaga</surname> <given-names>T</given-names></name><name><surname>Shioda</surname> <given-names>S</given-names></name><name><surname>Yamada</surname> <given-names>G</given-names></name><name><surname>Motoyama</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Mouse Shh is required for prechordal plate maintenance during brain and craniofacial morphogenesis</article-title><source>Developmental Biology</source><volume>327</volume><fpage>106</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2008.11.022</pub-id><pub-id pub-id-type="pmid">19103193</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname> <given-names>GU</given-names></name><name><surname>Yang</surname> <given-names>YJ</given-names></name><name><surname>Jiang</surname> <given-names>G</given-names></name><name><surname>Hong</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>HJ</given-names></name><name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Neogenin regulates skeletal myofiber size and focal adhesion kinase and extracellular signal-regulated kinase activities in vivo and in vitro</article-title><source>Molecular Biology of the Cell</source><volume>20</volume><fpage>4920</fpage><lpage>4931</lpage><pub-id pub-id-type="doi">10.1091/mbc.e09-06-0491</pub-id><pub-id pub-id-type="pmid">19812254</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname> <given-names>GU</given-names></name><name><surname>Domené</surname> <given-names>S</given-names></name><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Schachter</surname> <given-names>K</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mutations in CDON, encoding a hedgehog receptor, result in Holoprosencephaly and defective interactions with other hedgehog receptors</article-title><source>The American Journal of Human Genetics</source><volume>89</volume><fpage>231</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2011.07.001</pub-id><pub-id pub-id-type="pmid">21802063</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname> <given-names>V</given-names></name><name><surname>Lang</surname> <given-names>M</given-names></name><name><surname>Krens</surname> <given-names>SFG</given-names></name><name><surname>Pradhan</surname> <given-names>SJ</given-names></name><name><surname>Shamipour</surname> <given-names>S</given-names></name><name><surname>Sako</surname> <given-names>K</given-names></name><name><surname>Sikora</surname> <given-names>M</given-names></name><name><surname>Guet</surname> <given-names>CC</given-names></name><name><surname>Heisenberg</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An effective feedback loop between Cell-Cell contact duration and morphogen signaling determines cell fate</article-title><source>Developmental Cell</source><volume>43</volume><fpage>198</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2017.09.014</pub-id><pub-id pub-id-type="pmid">29033362</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beachy</surname> <given-names>PA</given-names></name><name><surname>Hymowitz</surname> <given-names>SG</given-names></name><name><surname>Lazarus</surname> <given-names>RA</given-names></name><name><surname>Leahy</surname> <given-names>DJ</given-names></name><name><surname>Siebold</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Interactions between hedgehog proteins and their binding partners come into view</article-title><source>Genes &amp; Development</source><volume>24</volume><fpage>2001</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1101/gad.1951710</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belo</surname> <given-names>JA</given-names></name><name><surname>Leyns</surname> <given-names>L</given-names></name><name><surname>Yamada</surname> <given-names>G</given-names></name><name><surname>De Robertis</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The prechordal midline of the chondrocranium is defective in Goosecoid-1 mouse mutants</article-title><source>Mechanisms of Development</source><volume>72</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(97)00204-9</pub-id><pub-id pub-id-type="pmid">9533949</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkun</surname> <given-names>L</given-names></name><name><surname>Slae</surname> <given-names>M</given-names></name><name><surname>Mor-Shaked</surname> <given-names>H</given-names></name><name><surname>Koplewitz</surname> <given-names>B</given-names></name><name><surname>Eventov-Friedman</surname> <given-names>S</given-names></name><name><surname>Harel</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Homozygous variants in MAPRE2 and CDON in individual with skin folds, growth delay, retinal coloboma, and pyloric Stenosis</article-title><source>American Journal of Medical Genetics. Part A</source><volume>179</volume><fpage>2454</fpage><lpage>2458</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.61355</pub-id><pub-id pub-id-type="pmid">31502381</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brons</surname> <given-names>IG</given-names></name><name><surname>Smithers</surname> <given-names>LE</given-names></name><name><surname>Trotter</surname> <given-names>MW</given-names></name><name><surname>Rugg-Gunn</surname> <given-names>P</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name><name><surname>Chuva de Sousa Lopes</surname> <given-names>SM</given-names></name><name><surname>Howlett</surname> <given-names>SK</given-names></name><name><surname>Clarkson</surname> <given-names>A</given-names></name><name><surname>Ahrlund-Richter</surname> <given-names>L</given-names></name><name><surname>Pedersen</surname> <given-names>RA</given-names></name><name><surname>Vallier</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Derivation of pluripotent epiblast stem cells from mammalian embryos</article-title><source>Nature</source><volume>448</volume><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1038/nature05950</pub-id><pub-id pub-id-type="pmid">17597762</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chng</surname> <given-names>Z</given-names></name><name><surname>Teo</surname> <given-names>A</given-names></name><name><surname>Pedersen</surname> <given-names>RA</given-names></name><name><surname>Vallier</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells</article-title><source>Cell Stem Cell</source><volume>6</volume><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2009.11.015</pub-id><pub-id pub-id-type="pmid">20074535</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname> <given-names>A</given-names></name><name><surname>Christa</surname> <given-names>A</given-names></name><name><surname>Kur</surname> <given-names>E</given-names></name><name><surname>Lioubinski</surname> <given-names>O</given-names></name><name><surname>Bachmann</surname> <given-names>S</given-names></name><name><surname>Willnow</surname> <given-names>TE</given-names></name><name><surname>Hammes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>LRP2 is an auxiliary SHH receptor required to condition the forebrain ventral midline for inductive signals</article-title><source>Developmental Cell</source><volume>22</volume><fpage>268</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.11.023</pub-id><pub-id pub-id-type="pmid">22340494</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Jeays-Ward</surname> <given-names>K</given-names></name><name><surname>Price</surname> <given-names>SM</given-names></name><name><surname>Placzek</surname> <given-names>M</given-names></name><name><surname>Shen</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Non-cell-autonomous role for cripto in axial midline formation during vertebrate embryogenesis</article-title><source>Development</source><volume>132</volume><fpage>5539</fpage><lpage>5551</lpage><pub-id pub-id-type="doi">10.1242/dev.02157</pub-id><pub-id pub-id-type="pmid">16291788</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Holoprosencephaly: clinical, anatomic, and molecular dimensions</article-title><source>Birth Defects Research Part A: Clinical and Molecular Teratology</source><volume>76</volume><fpage>658</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1002/bdra.20295</pub-id><pub-id pub-id-type="pmid">17001700</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>MM</given-names></name><name><surname>Shiota</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Teratogenesis of holoprosencephaly</article-title><source>American Journal of Medical Genetics</source><volume>109</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1002/ajmg.10258</pub-id><pub-id pub-id-type="pmid">11932986</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname> <given-names>F</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Microform holoprosencephaly in mice that lack the Ig superfamily member Cdon</article-title><source>Current Biology</source><volume>13</volume><fpage>411</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(03)00088-5</pub-id><pub-id pub-id-type="pmid">12620190</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constam</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Riding shotgun: a dual role for the epidermal growth factor-Cripto/FRL-1/Cryptic protein cripto in nodal trafficking</article-title><source>Traffic</source><volume>10</volume><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2009.00874.x</pub-id><pub-id pub-id-type="pmid">19302412</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordero</surname> <given-names>D</given-names></name><name><surname>Marcucio</surname> <given-names>R</given-names></name><name><surname>Hu</surname> <given-names>D</given-names></name><name><surname>Gaffield</surname> <given-names>W</given-names></name><name><surname>Tapadia</surname> <given-names>M</given-names></name><name><surname>Helms</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Temporal perturbations in sonic hedgehog signaling elicit the spectrum of holoprosencephaly phenotypes</article-title><source>Journal of Clinical Investigation</source><volume>114</volume><fpage>485</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1172/JCI200419596</pub-id><pub-id pub-id-type="pmid">15314685</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croen</surname> <given-names>LA</given-names></name><name><surname>Shaw</surname> <given-names>GM</given-names></name><name><surname>Lammer</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Risk factors for cytogenetically normal holoprosencephaly in California: a population-based case-control study</article-title><source>American Journal of Medical Genetics</source><volume>90</volume><fpage>320</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(20000214)90:4&lt;320::AID-AJMG11&gt;3.0.CO;2-8</pub-id><pub-id pub-id-type="pmid">10710231</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croy</surname> <given-names>JE</given-names></name><name><surname>Shin</surname> <given-names>WD</given-names></name><name><surname>Knauer</surname> <given-names>MF</given-names></name><name><surname>Knauer</surname> <given-names>DJ</given-names></name><name><surname>Komives</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>All three LDL receptor homology regions of the LDL receptor-related protein bind multiple ligands</article-title><source>Biochemistry</source><volume>42</volume><fpage>13049</fpage><lpage>13057</lpage><pub-id pub-id-type="doi">10.1021/bi034752s</pub-id><pub-id pub-id-type="pmid">14596620</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Yan</surname> <given-names>YT</given-names></name><name><surname>Chen</surname> <given-names>A</given-names></name><name><surname>Desai</surname> <given-names>N</given-names></name><name><surname>Wynshaw-Boris</surname> <given-names>A</given-names></name><name><surname>Shen</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo</article-title><source>Nature</source><volume>395</volume><fpage>702</fpage><lpage>707</lpage><pub-id pub-id-type="doi">10.1038/27215</pub-id><pub-id pub-id-type="pmid">9790191</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname> <given-names>J</given-names></name><name><surname>Sulik</surname> <given-names>KK</given-names></name><name><surname>Chen</surname> <given-names>S-yu</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Nrf2-Mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders</article-title><source>Antioxidants</source><volume>10</volume><fpage>2023</fpage><lpage>2033</lpage><pub-id pub-id-type="doi">10.1089/ars.2007.2019</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubourg</surname> <given-names>C</given-names></name><name><surname>Kim</surname> <given-names>A</given-names></name><name><surname>Watrin</surname> <given-names>E</given-names></name><name><surname>de Tayrac</surname> <given-names>M</given-names></name><name><surname>Odent</surname> <given-names>S</given-names></name><name><surname>David</surname> <given-names>V</given-names></name><name><surname>Dupé</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Recent advances in understanding inheritance of holoprosencephaly</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>178</volume><fpage>258</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.31619</pub-id><pub-id pub-id-type="pmid">29785796</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Echelard</surname> <given-names>Y</given-names></name><name><surname>Epstein</surname> <given-names>DJ</given-names></name><name><surname>St-Jacques</surname> <given-names>B</given-names></name><name><surname>Shen</surname> <given-names>L</given-names></name><name><surname>Mohler</surname> <given-names>J</given-names></name><name><surname>McMahon</surname> <given-names>JA</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity</article-title><source>Cell</source><volume>75</volume><fpage>1417</fpage><lpage>1430</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90627-3</pub-id><pub-id pub-id-type="pmid">7916661</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filosa</surname> <given-names>S</given-names></name><name><surname>Rivera-Pérez</surname> <given-names>JA</given-names></name><name><surname>Gómez</surname> <given-names>AP</given-names></name><name><surname>Gansmuller</surname> <given-names>A</given-names></name><name><surname>Sasaki</surname> <given-names>H</given-names></name><name><surname>Behringer</surname> <given-names>RR</given-names></name><name><surname>Ang</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Goosecoid and HNF-3β genetically interact to regulate neural tube patterning during mouse embryogenesis</article-title><source>Development</source><volume>124</volume><fpage>2843</fpage><lpage>2854</lpage><pub-id pub-id-type="pmid">9226455</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geng</surname> <given-names>X</given-names></name><name><surname>Oliver</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pathogenesis of holoprosencephaly</article-title><source>Journal of Clinical Investigation</source><volume>119</volume><fpage>1403</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1172/JCI38937</pub-id><pub-id pub-id-type="pmid">19487816</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname> <given-names>OH</given-names></name><name><surname>Gurdon</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Nuclear exclusion of Smad2 is a mechanism leading to loss of competence</article-title><source>Nature Cell Biology</source><volume>4</volume><fpage>519</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/ncb812</pub-id><pub-id pub-id-type="pmid">12068307</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyne</surname> <given-names>GW</given-names></name><name><surname>Melberg</surname> <given-names>CG</given-names></name><name><surname>Doroodchi</surname> <given-names>P</given-names></name><name><surname>Parins</surname> <given-names>KF</given-names></name><name><surname>Kietzman</surname> <given-names>HW</given-names></name><name><surname>Everson</surname> <given-names>JL</given-names></name><name><surname>Ansen-Wilson</surname> <given-names>LJ</given-names></name><name><surname>Lipinski</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Definition of critical periods for hedgehog pathway antagonist-induced holoprosencephaly, cleft lip, and cleft palate</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0120517</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0120517</pub-id><pub-id pub-id-type="pmid">25793997</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>M</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title><italic>Cdon</italic> mutation and fetal ethanol exposure synergize to produce midline signaling defects and holoprosencephaly spectrum disorders in mice</article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002999</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002999</pub-id><pub-id pub-id-type="pmid">23071453</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>M</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rescue of holoprosencephaly in fetal alcohol-exposed cdon mutant mice by reduced gene dosage of Ptch1</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e79269</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0079269</pub-id><pub-id pub-id-type="pmid">24244464</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>M</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ethanol itself is a holoprosencephaly-inducing teratogen</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0176440</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0176440</pub-id><pub-id pub-id-type="pmid">28441416</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname> <given-names>M</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Modeling the complex etiology of holoprosencephaly in mice</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>178</volume><fpage>140</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.31611</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Balmer</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>F</given-names></name><name><surname>Fidalgo</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Guallar</surname> <given-names>D</given-names></name><name><surname>Hadjantonakis</surname> <given-names>AK</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Zfp281 is essential for mouse epiblast maturation through transcriptional and epigenetic control of nodal signaling</article-title><source>eLife</source><volume>6</volume><elocation-id>e33333</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.33333</pub-id><pub-id pub-id-type="pmid">29168693</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izzi</surname> <given-names>L</given-names></name><name><surname>Lévesque</surname> <given-names>M</given-names></name><name><surname>Morin</surname> <given-names>S</given-names></name><name><surname>Laniel</surname> <given-names>D</given-names></name><name><surname>Wilkes</surname> <given-names>BC</given-names></name><name><surname>Mille</surname> <given-names>F</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Allen</surname> <given-names>BL</given-names></name><name><surname>Charron</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Boc and Gas1 each form distinct shh receptor complexes with Ptch1 and are required for Shh-mediated cell proliferation</article-title><source>Developmental Cell</source><volume>20</volume><fpage>788</fpage><lpage>801</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.04.017</pub-id><pub-id pub-id-type="pmid">21664577</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname> <given-names>MH</given-names></name><name><surname>Ho</surname> <given-names>SM</given-names></name><name><surname>Vuong</surname> <given-names>TA</given-names></name><name><surname>Jo</surname> <given-names>SB</given-names></name><name><surname>Liu</surname> <given-names>G</given-names></name><name><surname>Aaronson</surname> <given-names>SA</given-names></name><name><surname>Leem</surname> <given-names>YE</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cdo suppresses canonical wnt signalling via interaction with Lrp6 thereby promoting neuronal differentiation</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5455</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6455</pub-id><pub-id pub-id-type="pmid">25406935</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>CY</given-names></name><name><surname>Rasmussen</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Non-genetic risk factors for holoprosencephaly</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>154C</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.30242</pub-id><pub-id pub-id-type="pmid">20104598</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Mulieri</surname> <given-names>PJ</given-names></name><name><surname>Hu</surname> <given-names>Y</given-names></name><name><surname>Taliana</surname> <given-names>L</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation</article-title><source>The EMBO Journal</source><volume>21</volume><fpage>114</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.1.114</pub-id><pub-id pub-id-type="pmid">11782431</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Feinleib</surname> <given-names>JL</given-names></name><name><surname>Knox</surname> <given-names>S</given-names></name><name><surname>Ketteringham</surname> <given-names>MA</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Promyogenic members of the Ig and cadherin families associate to positively regulate differentiation</article-title><source>PNAS</source><volume>100</volume><fpage>3989</fpage><lpage>3994</lpage><pub-id pub-id-type="doi">10.1073/pnas.0736565100</pub-id><pub-id pub-id-type="pmid">12634428</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Yi</surname> <given-names>MJ</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Feinleib</surname> <given-names>JL</given-names></name><name><surname>Cole</surname> <given-names>F</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Netrins and neogenin promote myotube formation</article-title><source>Journal of Cell Biology</source><volume>167</volume><fpage>493</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1083/jcb.200405039</pub-id><pub-id pub-id-type="pmid">15520228</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiecker</surname> <given-names>C</given-names></name><name><surname>Niehrs</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The role of prechordal mesendoderm in neural patterning</article-title><source>Current Opinion in Neurobiology</source><volume>11</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/S0959-4388(00)00170-7</pub-id><pub-id pub-id-type="pmid">11179869</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kietzman</surname> <given-names>HW</given-names></name><name><surname>Everson</surname> <given-names>JL</given-names></name><name><surname>Sulik</surname> <given-names>KK</given-names></name><name><surname>Lipinski</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The teratogenic effects of prenatal ethanol exposure are exacerbated by sonic hedgehog or GLI2 haploinsufficiency in the mouse</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e89448</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0089448</pub-id><pub-id pub-id-type="pmid">24586787</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname> <given-names>Y</given-names></name><name><surname>Kaufman-Francis</surname> <given-names>K</given-names></name><name><surname>Studdert</surname> <given-names>JB</given-names></name><name><surname>Steiner</surname> <given-names>KA</given-names></name><name><surname>Power</surname> <given-names>MD</given-names></name><name><surname>Loebel</surname> <given-names>DA</given-names></name><name><surname>Jones</surname> <given-names>V</given-names></name><name><surname>Hor</surname> <given-names>A</given-names></name><name><surname>de Alencastro</surname> <given-names>G</given-names></name><name><surname>Logan</surname> <given-names>GJ</given-names></name><name><surname>Teber</surname> <given-names>ET</given-names></name><name><surname>Tam</surname> <given-names>OH</given-names></name><name><surname>Stutz</surname> <given-names>MD</given-names></name><name><surname>Alexander</surname> <given-names>IE</given-names></name><name><surname>Pickett</surname> <given-names>HA</given-names></name><name><surname>Tam</surname> <given-names>PP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The transcriptional and functional properties of mouse epiblast stem cells resemble the anterior primitive streak</article-title><source>Cell Stem Cell</source><volume>14</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2013.09.014</pub-id><pub-id pub-id-type="pmid">24139757</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>JH</given-names></name><name><surname>Siebold</surname> <given-names>C</given-names></name><name><surname>Rohatgi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Biochemical mechanisms of vertebrate hedgehog signaling</article-title><source>Development</source><volume>146</volume><elocation-id>dev166892</elocation-id><pub-id pub-id-type="doi">10.1242/dev.166892</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Holoprosencephaly: new models, new insights</article-title><source>Expert Reviews in Molecular Medicine</source><volume>9</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1017/S1462399407000440</pub-id><pub-id pub-id-type="pmid">17888203</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krauss</surname> <given-names>RS</given-names></name><name><surname>Hong</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gene-Environment interactions and the etiology of birth defects</article-title><source>Current Topics in Developmental Biology</source><volume>116</volume><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2015.12.010</pub-id><pub-id pub-id-type="pmid">26970642</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kretzschmar</surname> <given-names>M</given-names></name><name><surname>Doody</surname> <given-names>J</given-names></name><name><surname>Timokhina</surname> <given-names>I</given-names></name><name><surname>Massagué</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras</article-title><source>Genes &amp; Development</source><volume>13</volume><fpage>804</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1101/gad.13.7.804</pub-id><pub-id pub-id-type="pmid">10197981</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacbawan</surname> <given-names>F</given-names></name><name><surname>Solomon</surname> <given-names>BD</given-names></name><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>El-Jaick</surname> <given-names>K</given-names></name><name><surname>Domené</surname> <given-names>S</given-names></name><name><surname>Vélez</surname> <given-names>JI</given-names></name><name><surname>Zhou</surname> <given-names>N</given-names></name><name><surname>Hadley</surname> <given-names>D</given-names></name><name><surname>Balog</surname> <given-names>JZ</given-names></name><name><surname>Long</surname> <given-names>R</given-names></name><name><surname>Fryer</surname> <given-names>A</given-names></name><name><surname>Smith</surname> <given-names>W</given-names></name><name><surname>Omar</surname> <given-names>S</given-names></name><name><surname>McLean</surname> <given-names>SD</given-names></name><name><surname>Clarkson</surname> <given-names>K</given-names></name><name><surname>Lichty</surname> <given-names>A</given-names></name><name><surname>Clegg</surname> <given-names>NJ</given-names></name><name><surname>Delgado</surname> <given-names>MR</given-names></name><name><surname>Levey</surname> <given-names>E</given-names></name><name><surname>Stashinko</surname> <given-names>E</given-names></name><name><surname>Potocki</surname> <given-names>L</given-names></name><name><surname>Vanallen</surname> <given-names>MI</given-names></name><name><surname>Clayton-Smith</surname> <given-names>J</given-names></name><name><surname>Donnai</surname> <given-names>D</given-names></name><name><surname>Bianchi</surname> <given-names>DW</given-names></name><name><surname>Juliusson</surname> <given-names>PB</given-names></name><name><surname>Njølstad</surname> <given-names>PR</given-names></name><name><surname>Brunner</surname> <given-names>HG</given-names></name><name><surname>Carey</surname> <given-names>JC</given-names></name><name><surname>Hehr</surname> <given-names>U</given-names></name><name><surname>Müsebeck</surname> <given-names>J</given-names></name><name><surname>Wieacker</surname> <given-names>PF</given-names></name><name><surname>Postra</surname> <given-names>A</given-names></name><name><surname>Hennekam</surname> <given-names>RC</given-names></name><name><surname>van den Boogaard</surname> <given-names>MJ</given-names></name><name><surname>van Haeringen</surname> <given-names>A</given-names></name><name><surname>Paulussen</surname> <given-names>A</given-names></name><name><surname>Herbergs</surname> <given-names>J</given-names></name><name><surname>Schrander-Stumpel</surname> <given-names>CT</given-names></name><name><surname>Janecke</surname> <given-names>AR</given-names></name><name><surname>Chitayat</surname> <given-names>D</given-names></name><name><surname>Hahn</surname> <given-names>J</given-names></name><name><surname>McDonald-McGinn</surname> <given-names>DM</given-names></name><name><surname>Zackai</surname> <given-names>EH</given-names></name><name><surname>Dobyns</surname> <given-names>WB</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function</article-title><source>Journal of Medical Genetics</source><volume>46</volume><fpage>389</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1136/jmg.2008.063818</pub-id><pub-id pub-id-type="pmid">19346217</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>RT</given-names></name><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Ingham</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hedgehog signalling</article-title><source>Development</source><volume>143</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1242/dev.120154</pub-id><pub-id pub-id-type="pmid">26839340</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leoncini</surname> <given-names>E</given-names></name><name><surname>Baranello</surname> <given-names>G</given-names></name><name><surname>Orioli</surname> <given-names>IM</given-names></name><name><surname>Annerén</surname> <given-names>G</given-names></name><name><surname>Bakker</surname> <given-names>M</given-names></name><name><surname>Bianchi</surname> <given-names>F</given-names></name><name><surname>Bower</surname> <given-names>C</given-names></name><name><surname>Canfield</surname> <given-names>MA</given-names></name><name><surname>Castilla</surname> <given-names>EE</given-names></name><name><surname>Cocchi</surname> <given-names>G</given-names></name><name><surname>Correa</surname> <given-names>A</given-names></name><name><surname>De Vigan</surname> <given-names>C</given-names></name><name><surname>Doray</surname> <given-names>B</given-names></name><name><surname>Feldkamp</surname> <given-names>ML</given-names></name><name><surname>Gatt</surname> <given-names>M</given-names></name><name><surname>Irgens</surname> <given-names>LM</given-names></name><name><surname>Lowry</surname> <given-names>RB</given-names></name><name><surname>Maraschini</surname> <given-names>A</given-names></name><name><surname>Mc Donnell</surname> <given-names>R</given-names></name><name><surname>Morgan</surname> <given-names>M</given-names></name><name><surname>Mutchinick</surname> <given-names>O</given-names></name><name><surname>Poetzsch</surname> <given-names>S</given-names></name><name><surname>Riley</surname> <given-names>M</given-names></name><name><surname>Ritvanen</surname> <given-names>A</given-names></name><name><surname>Gnansia</surname> <given-names>ER</given-names></name><name><surname>Scarano</surname> <given-names>G</given-names></name><name><surname>Sipek</surname> <given-names>A</given-names></name><name><surname>Tenconi</surname> <given-names>R</given-names></name><name><surname>Mastroiacovo</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Frequency of holoprosencephaly in the international clearinghouse birth defects surveillance systems: searching for population variations</article-title><source>Birth Defects Research Part A: Clinical and Molecular Teratology</source><volume>82</volume><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1002/bdra.20479</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lessard</surname> <given-names>SJ</given-names></name><name><surname>MacDonald</surname> <given-names>TL</given-names></name><name><surname>Pathak</surname> <given-names>P</given-names></name><name><surname>Han</surname> <given-names>MS</given-names></name><name><surname>Coffey</surname> <given-names>VG</given-names></name><name><surname>Edge</surname> <given-names>J</given-names></name><name><surname>Rivas</surname> <given-names>DA</given-names></name><name><surname>Hirshman</surname> <given-names>MF</given-names></name><name><surname>Davis</surname> <given-names>RJ</given-names></name><name><surname>Goodyear</surname> <given-names>LJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>JNK regulates muscle remodeling via myostatin/SMAD inhibition</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3030</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05439-3</pub-id><pub-id pub-id-type="pmid">30072727</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Song</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Peng</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>P</given-names></name><name><surname>Tang</surname> <given-names>K</given-names></name><name><surname>Rossant</surname> <given-names>J</given-names></name><name><surname>Jing</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ectodermal progenitors derived from epiblast stem cells by inhibition of nodal signaling</article-title><source>Journal of Molecular Cell Biology</source><volume>7</volume><fpage>455</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1093/jmcb/mjv030</pub-id><pub-id pub-id-type="pmid">25990320</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>He</surname> <given-names>Z</given-names></name><name><surname>Osteil</surname> <given-names>P</given-names></name><name><surname>Wilkie</surname> <given-names>E</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Cui</surname> <given-names>G</given-names></name><name><surname>Guo</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Peng</surname> <given-names>G</given-names></name><name><surname>Tam</surname> <given-names>PPL</given-names></name><name><surname>Jing</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Suppressing nodal signaling activity predisposes ectodermal differentiation of epiblast stem cells</article-title><source>Stem Cell Reports</source><volume>11</volume><fpage>43</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2018.05.019</pub-id><pub-id pub-id-type="pmid">30008328</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname> <given-names>LA</given-names></name><name><surname>Yamada</surname> <given-names>S</given-names></name><name><surname>Kuehn</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Genetic dissection of nodal function in patterning the mouse embryo</article-title><source>Development</source><volume>128</volume><fpage>1831</fpage><lpage>1843</lpage></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>M</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>N-cadherin Ligation, but not sonic hedgehog binding, initiates Cdo-dependent p38 / MAPK signaling in skeletal myoblasts</article-title><source>PNAS</source><volume>107</volume><fpage>4212</fpage><lpage>4217</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908883107</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname> <given-names>RC</given-names></name><name><surname>McComb</surname> <given-names>JA</given-names></name><name><surname>Schreurs</surname> <given-names>J</given-names></name><name><surname>Goldstein</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>A relationship between alcohol intoxication and the disordering of brain membranes by a series of short-chain alcohols</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>218</volume><fpage>669</fpage><lpage>675</lpage><pub-id pub-id-type="pmid">7264950</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcucio</surname> <given-names>RS</given-names></name><name><surname>Young</surname> <given-names>NM</given-names></name><name><surname>Hu</surname> <given-names>D</given-names></name><name><surname>Hallgrimsson</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanisms that underlie co-variation of the brain and face</article-title><source>Genesis</source><volume>49</volume><fpage>177</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1002/dvg.20710</pub-id><pub-id pub-id-type="pmid">21381182</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Massague</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Integration of smad and MAPK pathways: a link and a Linker revisited</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>2993</fpage><lpage>2997</lpage><pub-id pub-id-type="doi">10.1101/gad.1167003</pub-id><pub-id pub-id-type="pmid">14701870</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matt</surname> <given-names>N</given-names></name><name><surname>Schmidt</surname> <given-names>CK</given-names></name><name><surname>Dupé</surname> <given-names>V</given-names></name><name><surname>Dennefeld</surname> <given-names>C</given-names></name><name><surname>Nau</surname> <given-names>H</given-names></name><name><surname>Chambon</surname> <given-names>P</given-names></name><name><surname>Mark</surname> <given-names>M</given-names></name><name><surname>Ghyselinck</surname> <given-names>NB</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Contribution of cellular retinol-binding protein type 1 to retinol metabolism during mouse development</article-title><source>Developmental Dynamics</source><volume>233</volume><fpage>167</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20313</pub-id><pub-id pub-id-type="pmid">15765518</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAlhany</surname> <given-names>RE</given-names></name><name><surname>West</surname> <given-names>JR</given-names></name><name><surname>Miranda</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Glial-derived neurotrophic factor (GDNF) prevents ethanol-induced apoptosis and JUN kinase phosphorylation</article-title><source>Developmental Brain Research</source><volume>119</volume><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S0165-3806(99)00171-6</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>RA</given-names></name><name><surname>Barth</surname> <given-names>JL</given-names></name><name><surname>Chintalapudi</surname> <given-names>MR</given-names></name><name><surname>Knaak</surname> <given-names>C</given-names></name><name><surname>Argraves</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Megalin functions as an endocytic sonic hedgehog receptor</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>25660</fpage><lpage>25667</lpage><pub-id pub-id-type="doi">10.1074/jbc.M201933200</pub-id><pub-id pub-id-type="pmid">11964399</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>N</given-names></name><name><surname>Wetherill</surname> <given-names>L</given-names></name><name><surname>Lovely</surname> <given-names>CB</given-names></name><name><surname>Swartz</surname> <given-names>ME</given-names></name><name><surname>Foroud</surname> <given-names>TM</given-names></name><name><surname>Eberhart</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pdgfra protects against ethanol-induced craniofacial defects in a zebrafish model of FASD</article-title><source>Development</source><volume>140</volume><fpage>3254</fpage><lpage>3265</lpage><pub-id pub-id-type="doi">10.1242/dev.094938</pub-id><pub-id pub-id-type="pmid">23861062</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKarns</surname> <given-names>SC</given-names></name><name><surname>Hansch</surname> <given-names>C</given-names></name><name><surname>Caldwell</surname> <given-names>WS</given-names></name><name><surname>Morgan</surname> <given-names>WT</given-names></name><name><surname>Moore</surname> <given-names>SK</given-names></name><name><surname>Doolittle</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Correlation between hydrophobicity of short-chain aliphatic alcohols and their ability to alter plasma membrane integrity</article-title><source>Fundamental and Applied Toxicology</source><volume>36</volume><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1006/faat.1996.2252</pub-id><pub-id pub-id-type="pmid">9073468</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname> <given-names>AP</given-names></name><name><surname>Ingham</surname> <given-names>PW</given-names></name><name><surname>Tabin</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Developmental roles and clinical significance of hedgehog signaling</article-title><source>Current Topics in Developmental Biology</source><volume>53</volume><fpage>1</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/s0070-2153(03)53002-2</pub-id><pub-id pub-id-type="pmid">12509125</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meno</surname> <given-names>C</given-names></name><name><surname>Gritsman</surname> <given-names>K</given-names></name><name><surname>Ohishi</surname> <given-names>S</given-names></name><name><surname>Ohfuji</surname> <given-names>Y</given-names></name><name><surname>Heckscher</surname> <given-names>E</given-names></name><name><surname>Mochida</surname> <given-names>K</given-names></name><name><surname>Shimono</surname> <given-names>A</given-names></name><name><surname>Kondoh</surname> <given-names>H</given-names></name><name><surname>Talbot</surname> <given-names>WS</given-names></name><name><surname>Robertson</surname> <given-names>EJ</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name><name><surname>Hamada</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation</article-title><source>Molecular Cell</source><volume>4</volume><fpage>287</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80331-7</pub-id><pub-id pub-id-type="pmid">10518210</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Muenke</surname> <given-names>M</given-names></name><name><surname>Beachy</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2001">2001</year><chapter-title>Holoprosencephaly</chapter-title><person-group person-group-type="editor"><name><surname>Scriver</surname> <given-names>C. R</given-names></name><name><surname>Beaudet</surname> <given-names>A. L</given-names></name><name><surname>Sly</surname> <given-names>W. S</given-names></name><name><surname>Valle</surname> <given-names>D</given-names></name></person-group><source>The Metabolic &amp; Molecular Bases of Inherited Disease, </source><publisher-loc>New York</publisher-loc><publisher-name>McGraw-Hill</publisher-name><fpage>6203</fpage><lpage>6230</lpage><pub-id pub-id-type="doi">10.1023/A:1017418800320</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulieri</surname> <given-names>PJ</given-names></name><name><surname>Okada</surname> <given-names>A</given-names></name><name><surname>Sassoon</surname> <given-names>DA</given-names></name><name><surname>McConnell</surname> <given-names>SK</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Developmental expression pattern of the <italic>cdo</italic> gene</article-title><source>Developmental Dynamics</source><volume>219</volume><fpage>40</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1002/1097-0177(2000)9999:9999&lt;::AID-DVDY1032&gt;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10974670</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulieri</surname> <given-names>PJ</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Sassoon</surname> <given-names>DA</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Expression of the <italic>boc</italic> gene during murine embryogenesis</article-title><source>Developmental Dynamics</source><volume>223</volume><fpage>379</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.1002/dvdy.10063</pub-id><pub-id pub-id-type="pmid">11891987</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najm</surname> <given-names>FJ</given-names></name><name><surname>Chenoweth</surname> <given-names>JG</given-names></name><name><surname>Anderson</surname> <given-names>PD</given-names></name><name><surname>Nadeau</surname> <given-names>JH</given-names></name><name><surname>Redline</surname> <given-names>RW</given-names></name><name><surname>McKay</surname> <given-names>RD</given-names></name><name><surname>Tesar</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Isolation of epiblast stem cells from preimplantation mouse embryos</article-title><source>Cell Stem Cell</source><volume>8</volume><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2011.01.016</pub-id><pub-id pub-id-type="pmid">21362571</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>National Birth Defects Prevention Study</collab><name><surname>Miller</surname> <given-names>EA</given-names></name><name><surname>Rasmussen</surname> <given-names>SA</given-names></name><name><surname>Siega-Riz</surname> <given-names>AM</given-names></name><name><surname>Frías</surname> <given-names>JL</given-names></name><name><surname>Honein</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Risk factors for non-syndromic holoprosencephaly in the national birth defects prevention study</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>154C</volume><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.30244</pub-id><pub-id pub-id-type="pmid">20104597</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>NISC Comparative Sequencing Program</collab><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Hu</surname> <given-names>P</given-names></name><name><surname>Marino</surname> <given-names>J</given-names></name><name><surname>Hong</surname> <given-names>S</given-names></name><name><surname>Hart</surname> <given-names>R</given-names></name><name><surname>Berger</surname> <given-names>S</given-names></name><name><surname>Martinez</surname> <given-names>A</given-names></name><name><surname>Abe</surname> <given-names>Y</given-names></name><name><surname>Kruszka</surname> <given-names>P</given-names></name><name><surname>Thomas</surname> <given-names>JW</given-names></name><name><surname>Mullikin</surname> <given-names>JC</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Wong</surname> <given-names>WSW</given-names></name><name><surname>Niederhuber</surname> <given-names>JE</given-names></name><name><surname>Solomon</surname> <given-names>BD</given-names></name><name><surname>Richieri-Costa</surname> <given-names>A</given-names></name><name><surname>Ribeiro-Bicudo</surname> <given-names>LA</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Common genetic causes of holoprosencephaly are limited to a small set of evolutionarily conserved driver genes of midline development coordinated by TGF-β, hedgehog, and FGF signaling</article-title><source>Human Mutation</source><volume>39</volume><fpage>1416</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.1002/humu.23590</pub-id><pub-id pub-id-type="pmid">29992659</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Smad2 role in mesoderm formation, left-right patterning and craniofacial development</article-title><source>Nature</source><volume>393</volume><fpage>786</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1038/31693</pub-id><pub-id pub-id-type="pmid">9655392</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauklin</surname> <given-names>S</given-names></name><name><surname>Vallier</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Activin/Nodal signalling in stem cells</article-title><source>Development</source><volume>142</volume><fpage>607</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1242/dev.091769</pub-id><pub-id pub-id-type="pmid">25670788</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrov</surname> <given-names>K</given-names></name><name><surname>Wierbowski</surname> <given-names>BM</given-names></name><name><surname>Salic</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Sending and receiving hedgehog signals</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>33</volume><fpage>145</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100616-060847</pub-id><pub-id pub-id-type="pmid">28693388</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pineda-Alvarez</surname> <given-names>DE</given-names></name><name><surname>Solomon</surname> <given-names>BD</given-names></name><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Balog</surname> <given-names>JZ</given-names></name><name><surname>Hadley</surname> <given-names>DW</given-names></name><name><surname>Zein</surname> <given-names>WM</given-names></name><name><surname>Hadsall</surname> <given-names>CK</given-names></name><name><surname>Brooks</surname> <given-names>BP</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A broad range of ophthalmologic anomalies is part of the holoprosencephaly spectrum</article-title><source>American Journal of Medical Genetics Part A</source><volume>155</volume><fpage>2713</fpage><lpage>2720</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.34261</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>DR</given-names></name><name><surname>Williams</surname> <given-names>JS</given-names></name><name><surname>Hernandez-Lagunas</surname> <given-names>L</given-names></name><name><surname>Salcedo</surname> <given-names>E</given-names></name><name><surname>O'Brien</surname> <given-names>JH</given-names></name><name><surname>Artinger</surname> <given-names>KB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cdon promotes neural crest migration by regulating N-cadherin localization</article-title><source>Developmental Biology</source><volume>407</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.07.025</pub-id><pub-id pub-id-type="pmid">26256768</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>F</given-names></name><name><surname>Xu</surname> <given-names>M</given-names></name><name><surname>Frank</surname> <given-names>JA</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Ke</surname> <given-names>ZJ</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ethanol-induced damage to the developing spinal cord: the involvement of CCR2 signaling</article-title><source>Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease</source><volume>1863</volume><fpage>2746</fpage><lpage>2761</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2017.07.035</pub-id><pub-id pub-id-type="pmid">28778590</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rezaei</surname> <given-names>HB</given-names></name><name><surname>Kamato</surname> <given-names>D</given-names></name><name><surname>Ansari</surname> <given-names>G</given-names></name><name><surname>Osman</surname> <given-names>N</given-names></name><name><surname>Little</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cell biology of Smad2/3 Linker region phosphorylation in vascular smooth muscle</article-title><source>Clinical and Experimental Pharmacology and Physiology</source><volume>39</volume><fpage>661</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2011.05592.x</pub-id><pub-id pub-id-type="pmid">21883378</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dose-dependent nodal/Smad signals pattern the early mouse embryo</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>32</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.03.028</pub-id><pub-id pub-id-type="pmid">24704361</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Vélez</surname> <given-names>JI</given-names></name><name><surname>Zhou</surname> <given-names>N</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Utilizing prospective sequence analysis of SHH, ZIC2, SIX3 and TGIF in holoprosencephaly probands to describe the parameters limiting the observed frequency of mutant gene×gene interactions</article-title><source>Molecular Genetics and Metabolism</source><volume>105</volume><fpage>658</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1016/j.ymgme.2012.01.005</pub-id><pub-id pub-id-type="pmid">22310223</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Hu</surname> <given-names>P</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Holoprosencephaly in the genomics era</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>178</volume><fpage>165</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.31615</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Beachy</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Patterning of the embryonic forebrain</article-title><source>Current Opinion in Neurobiology</source><volume>8</volume><fpage>18</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/S0959-4388(98)80004-4</pub-id><pub-id pub-id-type="pmid">9568388</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Arrones</surname> <given-names>L</given-names></name><name><surname>Cardozo</surname> <given-names>M</given-names></name><name><surname>Nieto-Lopez</surname> <given-names>F</given-names></name><name><surname>Bovolenta</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cdon and Boc: Two transmembrane proteins implicated in cell-cell communication</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>44</volume><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2012.01.019</pub-id><pub-id pub-id-type="pmid">22326621</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schier</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nodal morphogens</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>1</volume><elocation-id>a003459</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a003459</pub-id><pub-id pub-id-type="pmid">20066122</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>MM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Nodal signaling: developmental roles and regulation</article-title><source>Development</source><volume>134</volume><fpage>1023</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1242/dev.000166</pub-id><pub-id pub-id-type="pmid">17287255</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiota</surname> <given-names>K</given-names></name><name><surname>Yamada</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Early pathogenesis of holoprosencephaly</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>154C</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.30248</pub-id><pub-id pub-id-type="pmid">20104600</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname> <given-names>BD</given-names></name><name><surname>Mercier</surname> <given-names>S</given-names></name><name><surname>Vélez</surname> <given-names>JI</given-names></name><name><surname>Pineda-Alvarez</surname> <given-names>DE</given-names></name><name><surname>Wyllie</surname> <given-names>A</given-names></name><name><surname>Zhou</surname> <given-names>N</given-names></name><name><surname>Dubourg</surname> <given-names>C</given-names></name><name><surname>David</surname> <given-names>V</given-names></name><name><surname>Odent</surname> <given-names>S</given-names></name><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Analysis of genotype-phenotype correlations in human holoprosencephaly</article-title><source>American Journal of Medical Genetics Part C: Seminars in Medical Genetics</source><volume>154C</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.30240</pub-id><pub-id pub-id-type="pmid">20104608</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname> <given-names>BD</given-names></name><name><surname>Bear</surname> <given-names>KA</given-names></name><name><surname>Wyllie</surname> <given-names>A</given-names></name><name><surname>Keaton</surname> <given-names>AA</given-names></name><name><surname>Dubourg</surname> <given-names>C</given-names></name><name><surname>David</surname> <given-names>V</given-names></name><name><surname>Mercier</surname> <given-names>S</given-names></name><name><surname>Odent</surname> <given-names>S</given-names></name><name><surname>Hehr</surname> <given-names>U</given-names></name><name><surname>Paulussen</surname> <given-names>A</given-names></name><name><surname>Clegg</surname> <given-names>NJ</given-names></name><name><surname>Delgado</surname> <given-names>MR</given-names></name><name><surname>Bale</surname> <given-names>SJ</given-names></name><name><surname>Lacbawan</surname> <given-names>F</given-names></name><name><surname>Ardinger</surname> <given-names>HH</given-names></name><name><surname>Aylsworth</surname> <given-names>AS</given-names></name><name><surname>Bhengu</surname> <given-names>NL</given-names></name><name><surname>Braddock</surname> <given-names>S</given-names></name><name><surname>Brookhyser</surname> <given-names>K</given-names></name><name><surname>Burton</surname> <given-names>B</given-names></name><name><surname>Gaspar</surname> <given-names>H</given-names></name><name><surname>Grix</surname> <given-names>A</given-names></name><name><surname>Horovitz</surname> <given-names>D</given-names></name><name><surname>Kanetzke</surname> <given-names>E</given-names></name><name><surname>Kayserili</surname> <given-names>H</given-names></name><name><surname>Lev</surname> <given-names>D</given-names></name><name><surname>Nikkel</surname> <given-names>SM</given-names></name><name><surname>Norton</surname> <given-names>M</given-names></name><name><surname>Roberts</surname> <given-names>R</given-names></name><name><surname>Saal</surname> <given-names>H</given-names></name><name><surname>Schaefer</surname> <given-names>GB</given-names></name><name><surname>Schneider</surname> <given-names>A</given-names></name><name><surname>Smith</surname> <given-names>EK</given-names></name><name><surname>Sowry</surname> <given-names>E</given-names></name><name><surname>Spence</surname> <given-names>MA</given-names></name><name><surname>Shalev</surname> <given-names>SA</given-names></name><name><surname>Steiner</surname> <given-names>CE</given-names></name><name><surname>Thompson</surname> <given-names>EM</given-names></name><name><surname>Winder</surname> <given-names>TL</given-names></name><name><surname>Balog</surname> <given-names>JZ</given-names></name><name><surname>Hadley</surname> <given-names>DW</given-names></name><name><surname>Zhou</surname> <given-names>N</given-names></name><name><surname>Pineda-Alvarez</surname> <given-names>DE</given-names></name><name><surname>Roessler</surname> <given-names>E</given-names></name><name><surname>Muenke</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genotypic and phenotypic analysis of 396 individuals with mutations in sonic hedgehog</article-title><source>Journal of Medical Genetics</source><volume>49</volume><fpage>473</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101008</pub-id><pub-id pub-id-type="pmid">22791840</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>J</given-names></name><name><surname>Oh</surname> <given-names>SP</given-names></name><name><surname>Schrewe</surname> <given-names>H</given-names></name><name><surname>Nomura</surname> <given-names>M</given-names></name><name><surname>Lei</surname> <given-names>H</given-names></name><name><surname>Okano</surname> <given-names>M</given-names></name><name><surname>Gridley</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The type II activin receptors are essential for egg cylinder growth, Gastrulation, and rostral head development in mice</article-title><source>Developmental Biology</source><volume>213</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9370</pub-id><pub-id pub-id-type="pmid">10452853</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sparrow</surname> <given-names>DB</given-names></name><name><surname>Chapman</surname> <given-names>G</given-names></name><name><surname>Smith</surname> <given-names>AJ</given-names></name><name><surname>Mattar</surname> <given-names>MZ</given-names></name><name><surname>Major</surname> <given-names>JA</given-names></name><name><surname>O'Reilly</surname> <given-names>VC</given-names></name><name><surname>Saga</surname> <given-names>Y</given-names></name><name><surname>Zackai</surname> <given-names>EH</given-names></name><name><surname>Dormans</surname> <given-names>JP</given-names></name><name><surname>Alman</surname> <given-names>BA</given-names></name><name><surname>McGregor</surname> <given-names>L</given-names></name><name><surname>Kageyama</surname> <given-names>R</given-names></name><name><surname>Kusumi</surname> <given-names>K</given-names></name><name><surname>Dunwoodie</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A mechanism for gene-environment interaction in the etiology of congenital scoliosis</article-title><source>Cell</source><volume>149</volume><fpage>295</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.02.054</pub-id><pub-id pub-id-type="pmid">22484060</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spoelgen</surname> <given-names>R</given-names></name><name><surname>Hammes</surname> <given-names>A</given-names></name><name><surname>Anzenberger</surname> <given-names>U</given-names></name><name><surname>Zechner</surname> <given-names>D</given-names></name><name><surname>Andersen</surname> <given-names>OM</given-names></name><name><surname>Jerchow</surname> <given-names>B</given-names></name><name><surname>Willnow</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>LRP2/megalin is required for patterning of the ventral telencephalon</article-title><source>Development</source><volume>132</volume><fpage>405</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1242/dev.01580</pub-id><pub-id pub-id-type="pmid">15623804</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulik</surname> <given-names>KK</given-names></name><name><surname>Johnston</surname> <given-names>MC</given-names></name><name><surname>Webb</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Fetal alcohol syndrome: embryogenesis in a mouse model</article-title><source>Science</source><volume>214</volume><fpage>936</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1126/science.6795717</pub-id><pub-id pub-id-type="pmid">6795717</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname> <given-names>AD</given-names></name><name><surname>Reefhuis</surname> <given-names>J</given-names></name><name><surname>Taliano</surname> <given-names>J</given-names></name><name><surname>Rasmussen</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nongenetic risk factors for holoprosencephaly: an updated review of the epidemiologic literature</article-title><source>American Journal of Genet C: Seminars in Medical Genetics</source><volume>178</volume><fpage>151</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1002/ajmg.c.31614</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenzen</surname> <given-names>T</given-names></name><name><surname>Allen</surname> <given-names>BL</given-names></name><name><surname>Cole</surname> <given-names>F</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The cell surface membrane proteins cdo and boc are components and targets of the hedgehog signaling pathway and feedback network in mice</article-title><source>Developmental Cell</source><volume>10</volume><fpage>647</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.04.004</pub-id><pub-id pub-id-type="pmid">16647304</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakiridis</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Blin</surname> <given-names>G</given-names></name><name><surname>Skylaki</surname> <given-names>S</given-names></name><name><surname>Wymeersch</surname> <given-names>F</given-names></name><name><surname>Osorno</surname> <given-names>R</given-names></name><name><surname>Economou</surname> <given-names>C</given-names></name><name><surname>Karagianni</surname> <given-names>E</given-names></name><name><surname>Zhao</surname> <given-names>S</given-names></name><name><surname>Lowell</surname> <given-names>S</given-names></name><name><surname>Wilson</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Distinct Wnt-driven primitive streak-like populations reflect in vivo lineage precursors</article-title><source>Development</source><volume>141</volume><fpage>1209</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1242/dev.101014</pub-id><pub-id pub-id-type="pmid">24595287</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallier</surname> <given-names>L</given-names></name><name><surname>Mendjan</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>S</given-names></name><name><surname>Chng</surname> <given-names>Z</given-names></name><name><surname>Teo</surname> <given-names>A</given-names></name><name><surname>Smithers</surname> <given-names>LE</given-names></name><name><surname>Trotter</surname> <given-names>MW</given-names></name><name><surname>Cho</surname> <given-names>CH</given-names></name><name><surname>Martinez</surname> <given-names>A</given-names></name><name><surname>Rugg-Gunn</surname> <given-names>P</given-names></name><name><surname>Brons</surname> <given-names>G</given-names></name><name><surname>Pedersen</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Activin/Nodal signalling maintains pluripotency by controlling nanog expression</article-title><source>Development</source><volume>136</volume><fpage>1339</fpage><lpage>1349</lpage><pub-id pub-id-type="doi">10.1242/dev.033951</pub-id><pub-id pub-id-type="pmid">19279133</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willnow</surname> <given-names>TE</given-names></name><name><surname>Hilpert</surname> <given-names>J</given-names></name><name><surname>Armstrong</surname> <given-names>SA</given-names></name><name><surname>Rohlmann</surname> <given-names>A</given-names></name><name><surname>Hammer</surname> <given-names>RE</given-names></name><name><surname>Burns</surname> <given-names>DK</given-names></name><name><surname>Herz</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Defective forebrain development in mice lacking gp330/megalin</article-title><source>PNAS</source><volume>93</volume><fpage>8460</fpage><lpage>8464</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.16.8460</pub-id><pub-id pub-id-type="pmid">8710893</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willnow</surname> <given-names>TE</given-names></name><name><surname>Christ</surname> <given-names>A</given-names></name><name><surname>Hammes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Endocytic receptor-mediated control of morphogen signaling</article-title><source>Development</source><volume>139</volume><fpage>4311</fpage><lpage>4319</lpage><pub-id pub-id-type="doi">10.1242/dev.084467</pub-id><pub-id pub-id-type="pmid">23132241</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willnow</surname> <given-names>TE</given-names></name><name><surname>Christ</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Endocytic receptor LRP2/megalin—of holoprosencephaly and renal Fanconi syndrome</article-title><source>Pflügers Archiv - European Journal of Physiology</source><volume>469</volume><fpage>907</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1007/s00424-017-1992-0</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalc</surname> <given-names>A</given-names></name><name><surname>Rattenbach</surname> <given-names>R</given-names></name><name><surname>Auradé</surname> <given-names>F</given-names></name><name><surname>Cadot</surname> <given-names>B</given-names></name><name><surname>Relaix</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pax3 and Pax7 play essential safeguard functions against environmental stress-induced birth defects</article-title><source>Developmental Cell</source><volume>33</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.02.006</pub-id><pub-id pub-id-type="pmid">25800090</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>XM</given-names></name><name><surname>Ramalho-Santos</surname> <given-names>M</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Smoothened mutants reveal redundant roles for shh and ihh signaling including regulation of L/R symmetry by the mouse node</article-title><source>Cell</source><volume>106</volume><fpage>781</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00385-3</pub-id><pub-id pub-id-type="pmid">11517919</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Cole</surname> <given-names>F</given-names></name><name><surname>Yi</surname> <given-names>MJ</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cdo functions at multiple points in the sonic hedgehog pathway, and Cdo-deficient mice accurately model human holoprosencephaly</article-title><source>Developmental Cell</source><volume>10</volume><fpage>657</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.04.005</pub-id><pub-id pub-id-type="pmid">16647303</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W</given-names></name><name><surname>Mulieri</surname> <given-names>PJ</given-names></name><name><surname>Gaio</surname> <given-names>U</given-names></name><name><surname>Bae</surname> <given-names>GU</given-names></name><name><surname>Krauss</surname> <given-names>RS</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Ocular abnormalities in mice lacking the immunoglobulin superfamily member Cdo</article-title><source>FEBS Journal</source><volume>276</volume><fpage>5998</fpage><lpage>6010</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2009.07310.x</pub-id><pub-id pub-id-type="pmid">19754878</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Mann</surname> <given-names>RK</given-names></name><name><surname>Sever</surname> <given-names>N</given-names></name><name><surname>Beachy</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genetic and biochemical definition of the hedgehog receptor</article-title><source>Genes &amp; Development</source><volume>24</volume><fpage>57</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1101/gad.1870310</pub-id><pub-id pub-id-type="pmid">20048000</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60351.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Bovolenta</surname><given-names>Paola</given-names></name><role>Reviewing Editor</role><aff><institution>CSIC-UAM</institution><country>Spain</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lipinski</surname><given-names>Robert</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib><contrib contrib-type="reviewer"><name><surname>Kruszka</surname><given-names>Paul</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The manuscript dissects the interaction between alcohol teratogenesis and <italic>Cdon</italic> mutations as causes of brain and face malformations typical of a rare birth defect known as holoprosencephaly. The manuscript shows that mechanistically the two factors converge in a very restricted temporal window on the Nodal signaling pathway, providing novel insight on how an environmental factor can impinge upon an otherwise silent genetic alteration.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>Cdon</italic> mutation and fetal alcohol converge on Nodal signaling in a mouse model of holoprosencephaly&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by Marianne Bronner as the Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Robert Lipinski (Reviewer #1); Paul Kruszka (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>Holoprosencephaly (HPE) is a common birth defect in human with genetic and environmental causes. Prominent among the genetic causes are component of the Nodal and Hedgehog signaling pathways. In previous studies the group of R. Krauss has shown that mutations in the <italic>Cdon</italic> gene (which is known to act as a HH binding protein) and in utero exposure to ethanol produced HPE with a penetrance not observed when the two factors are considered individually. The present study offers an important mechanistic insight into mechanism underlying this synergy. It shows that Nodal is the target upon which prenatal alcohol exposure converges with <italic>Cdon</italic> mutations in causing the brain and face malformations of holoprosencephaly. The manuscript thus expands on the present understanding of alcohol teratogenesis and <italic>Cdon</italic> role in embryogenesis demonstrating how these factors interact.</p><p>Essential revisions:</p><p>There is general consensus that this a very valuable and well performed study that adds important information on the interaction between environmental and genetic factors in the development of HPE.</p><p>There are however a number of issues that need your attention:</p><p>1) The data rule out the participation of HH signaling in the presented phenotype are not strong and mostly based on previous studies in which differences in mouse strain, breeding etc. may make the comparison with the present study questionable. Thus, at minimum, you reconsider the interpretation of the data and tone down the conclusions.</p><p>2) There is also too much speculation related to the role of CDON variants in humans. This needs to be addressed.</p><p>3) Please also address the state of p-SMAD2C in ethanol treated embryos and in <italic>Cdon</italic>, <italic>Lrp2</italic> double mutant embryos.</p><p>4) To sustain the conclusions related to the Nodal signaling activity please also analyze additional target genes such as <italic>Gsc</italic>.</p><p><italic>Reviewer #1:</italic></p><p>General assessment: The manuscript by Hong et al. provides evidence pointing toward Nodal as a target upon which prenatal alcohol exposure converges with <italic>Cdon</italic> mutations in causing the brain and face malformations of holoprosencephaly. Dissecting the interaction of specific genetic and chemical influences is an important but challenging focus of birth defects research. The manuscript offers an exceptional degree of mechanistic insight that challenges the existing understanding of alcohol teratogenesis, expands the role of <italic>Cdon</italic> in embryogenesis, and points to how these factors interact. While some interpretations rely on interpolation of historical data and probably should be dialled back, on balance the study appears high quality and the findings novel, making the work as a whole a significant advance in the field.</p><p>1) The data supporting ethanol acting (at least in part) upstream of HH on Nodal is strong and compelling. However, the argument against alcohol acting (at least in part) on HH pathway is less convincing, not supported by strong direct evidence, and relies on comparison of new and historical data. For example, the authors state that the window of sensitivity to EtOH-induced HPE in 129S6 <italic>Cdon</italic><sup>-/-</sup> mice is closed by E7.5, prior to <italic>Shh</italic> expression in the midline which begins at E7.5-7.75 but contemporaneous evidence is lacking. The strain of mice, breeding strategy, and staging nomenclature may have differed between the present study and that cited for <italic>Shh</italic> expression timing (Echalard). The authors show no effect of ethanol exposure at E7.5. Dosing at E7.25 however does have an effect but this follows a dose at E7.25 and another 4 hours later, making it likely that ethanol exposure persists through E7.5. Dialling back the interpretation of these data and focusing more on those supporting Nodal as a newly identified target of ethanol and point of synergism between ethanol and <italic>Cdon</italic> would mitigate this concern. This need not detract from the impact of the novel findings presented. As the authors note, alcohol may perturb cell membranes and receptor trafficking/function, so mechanisms/targets are unlikely to be mutually exclusive.</p><p><italic>Reviewer #2:</italic></p><p>This is a very well written manuscript and important for HPE research. I believe this is a &quot;must publish&quot; manuscript. This study addresses the &quot;Holy Grail&quot; of genetics of modifiers, incomplete penetrance and variable expressivity. This study is also a beautiful continuation of this group's narrative on CDON and ETOH.</p><p>Until this study, CDON was thought to act mainly through HH signaling, and this is a first in showing the CDON-Nodal signaling relationship. The mouse knockout and epiblast stem cell experiments are fantastic and convincing. There few studies with this high-quality figures.</p><p>My most significant comment is that the authors speculate too much about the role of CDON variants in humans. If you dig deep into the published literature, there is not a strong association with CDON and HPE in humans (driver or modifier). There is one fact that cannot be ignored: in healthy humans, loss of function variants in CDON is common, which is very different from the known associated HPE genes such as SHH, ZIC2, SIX3, STAG2, SMC1A etc. Therefore, it will take a large epidemiologic study to connect CDON and ETOH in humans. The data is just not there in humans to connect alcohol and CDON variation (yet).</p><p>1) Introduction: &quot;animal models are required…&quot; is debatable. The mouse model behaves very differently than humans in regard to the genetics of HPE; for example, only a heterozygous variant in SHH results in HPE in humans where heterozygous mice with SHH variants are normal. Animal models are a surrogate for human studies that are underpowered; especially, in conditions such as HPE which is rare. There have been attempts in humans to answer the question of environmental effects on HPE, see Addissie et al., 2020, again study power is an issue.</p><p>2) Introduction: Addissie et al., 2020 should be referenced here. Also, recommend reviewing Addissie et al.</p><p>3) I do not believe there is sufficient evidence to associate CDON with HPE in humans. In the largest study mentioning CDON's association with HPE, some of the variants were (1) transmitted from a parent; and (2) a missense variant without functional evidence of pathogenicity. These CDON variants are variants of unknown significance. Commercial labs often misinterpret these gene associations with HPE and it is very important to be precise here, i.e. see https://www.invitae.com/en/physician/tests/04424/#info-panel-assay_information. See my next comment. I believe the authors have misinterpreted the findings in Roessler et al., 2018a.</p><p>4) It should be noted that CDON loss of function variants are commonly found in healthy human individuals (observed / expected ration of 0.58; https://gnomad.broadinstitute.org/gene/ENSG00000064309?dataset=gnomad_r2_1), showing that CDON loss of function variants are not constrained by evolution. This is very important and it supports the authors' findings that most alcohol is needed with a CDON variant to reach the HPE threshold in mice and most likely (though not proven) in humans.</p><p><italic>Reviewer #3:</italic></p><p>Holoprosencephaly (HPE) is a common birth defect in human. Many genes such as those in Nodal and Hedgehog signaling are implicated in HPE, but environmental factors also contribute. The authors previously showed that a mutation in <italic>Cdon</italic> gene or in utero exposure to ethanol individually had little effect, but the combination of both produced HPE with high penetrance. However, it was unknown how <italic>Cdon</italic> mutation and ethanol synergize for HPE.</p><p>In this paper, the authors conclude that <italic>Cdon</italic> and ethanol converge to Nodal signaling. Involvement of <italic>Cdon</italic> in Nodal signaling was supported by genetic and physical interaction between <italic>Cdon</italic> and Cripto (a coreceptor of Nodal). Effects of ethanol on Nodal signaling was examined with mouse epiblast stem cells, and ethanol was shown to inhibit C-terminal phosphorylation of SMAD2, a readout of Nodal activity. Collectively, it was concluded that <italic>Cdon</italic> mutation and in utero ethanol synergistically inhibit Nodal signaling, producing HPE.</p><p>In all, this paper provides a nice example showing how interaction between a gene and an environmental factor affects a particular developmental process. Since many of genetic disorders in human likely involve multiple factors, genetic and environmental factors, this paper has important messages. To be published in <italic>eLife</italic>, however, the following points need to be addressed.</p><p>1) Authors provide a nice set of data showing that ethanol inhibits SMAD2 C-terminal phosphorylation in mouse epiblast stem cells (Figure 2A, 2B). This is excellent. However, it is more important to see the effects of ethanol with mouse embryos. This can be done by staining of mouse embryos such as those shown in Figure 1 with the anti-phosphorylated SMAD2C (the antibody is commercially available and has been used by others). Similarly, I would like to suggest examining p-SMAD2C in <italic>Cdon</italic>, <italic>Lrp2</italic> double mutant embryos too (Figure 3A; whole mount staining may be easier at an earlier stage than E11.5). This would strengthen the conclusion that <italic>Cdon</italic> and ethanol synergistically affect Nodal signaling in mouse embryos.</p><p>2) <italic>Lefty2</italic> expression is regulated by Nodal, but <italic>Lefty2</italic> protein inhibits Nodal activity, which makes a complex network. It is preferable to examine additional Nodal target genes such as Gsc in Figure 1. Also, is Nodal expression maintained in <italic>Cdon</italic><sup>-/-</sup>, EtOH embryos (Figure 1)?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60351.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>There is general consensus that this a very valuable and well performed study that adds important information on the interaction between environmental and genetic factors in the development of HPE.</p><p>There are however a number of issues that need your attention:</p><p>1) The data rule out the participation of HH signaling in the presented phenotype are not strong and mostly based on previous studies in which differences in mouse strain, breeding etc. may make the comparison with the present study questionable. Thus, at minimum, you reconsider the interpretation of the data and tone down the conclusions.</p></disp-quote><p>We agree with the reviewer’s point and have modified the text in the Abstract, Results section, and Discussion section to temper our conclusions. Additionally, we state in the Discussion section, “Our findings do not exclude that EtOH may also target HH signaling in <italic>Cdon</italic><sup>-/-</sup> mice, but they are consistent with Nodal signaling being a major target of EtOH in HPE.”</p><disp-quote content-type="editor-comment"><p>2) There is also too much speculation related to the role of CDON variants in humans. This needs to be addressed.</p></disp-quote><p>We agree that the role of CDON variants in human HPE is not fully clear. We have made this overt in the Introduction.</p><disp-quote content-type="editor-comment"><p>3) Please also address the state of p-SMAD2C in ethanol treated embryos and in Cdon, Lrp2 double mutant embryos.</p></disp-quote><p>As described above, we will perform these experiments as soon as possible and report them as suggested by the editors. We have added text to the Discussion section to state explicitly that these experiments are required.</p><disp-quote content-type="editor-comment"><p>4) To sustain the conclusions related to the Nodal signaling activity please also analyze additional target genes such as Gsc.</p></disp-quote><p>We thank the reviewer for this comment. We have in fact analyzed expression of <italic>Gsc</italic> and <italic>FoxA2</italic>, two additional Nodal target genes important for PCP induction. Expression of <italic>Gsc</italic> and <italic>FoxA2</italic> are specifically reduced in EtOH-treated <italic>Cdon</italic> mutant embryos, similar to expression of <italic>Lefty2</italic>. These results were published in Hong and Krauss (2012), cited in the references. This was stated in the original version of the paper, but we have made this clearer in the revised manuscript (subsection <italic>“Cdon</italic> interacts genetically with Nodal pathway components” and Discussion section).</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>[…]</p><p>1) The data supporting ethanol acting (at least in part) upstream of HH on Nodal is strong and compelling. However, the argument against alcohol acting (at least in part) on HH pathway is less convincing, not supported by strong direct evidence, and relies on comparison of new and historical data. For example, the authors state that the window of sensitivity to EtOH-induced HPE in 129S6 Cdon<sup>-/-</sup> mice is closed by E7.5, prior to Shh expression in the midline which begins at E7.5-7.75 but contemporaneous evidence is lacking. The strain of mice, breeding strategy, and staging nomenclature may have differed between the present study and that cited for Shh expression timing (Echalard). The authors show no effect of ethanol exposure at E7.5. Dosing at E7.25 however does have an effect but this follows a dose at E7.25 and another 4 hours later, making it likely that ethanol exposure persists through E7.5. Dialling back the interpretation of these data and focusing more on those supporting Nodal as a newly identified target of ethanol and point of synergism between ethanol and Cdon would mitigate this concern. This need not detract from the impact of the novel findings presented. As the authors note, alcohol may perturb cell membranes and receptor trafficking/function, so mechanisms/targets are unlikely to be mutually exclusive.</p></disp-quote><p>We have made the requested changes to the text (please see the response to Essential revisions, point 1, above).</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>[…]</p><p>My most significant comment is that the authors speculate too much about the role of CDON variants in humans. If you dig deep into the published literature, there is not a strong association with CDON and HPE in humans (driver or modifier). There is one fact that cannot be ignored: in healthy humans, loss of function variants in CDON is common, which is very different from the known associated HPE genes such as SHH, ZIC2, SIX3, STAG2, SMC1A etc. Therefore, it will take a large epidemiologic study to connect CDON and ETOH in humans. The data is just not there in humans to connect alcohol and CDON variation (yet).</p></disp-quote><p>We have made the requested changes to the text (please see the response to Essential revisions, point 2, above).</p><disp-quote content-type="editor-comment"><p>1) Introduction: &quot;animal models are required…&quot; is debatable. The mouse model behaves very differently than humans in regard to the genetics of HPE; for example, only a heterozygous variant in SHH results in HPE in humans where heterozygous mice with SHH variants are normal. Animal models are a surrogate for human studies that are underpowered; especially, in conditions such as HPE which is rare. There have been attempts in humans to answer the question of environmental effects on HPE, see Addissie et al., 2020, again study power is an issue.</p></disp-quote><p>We thank the reviewer for this comment. We have substituted the word “valuable” for the word “required”. We point out that this statement is consistent with a statement from HPE epidemiologists: “More data from in vitro and animal models might be necessary to identify the most biologically plausible risk factors.” (Miller at al. 2010, in the references).</p><p>We agree the Addissie et al., paper is highly relevant to the discussion and have cited it twice in the text (Results section).</p><disp-quote content-type="editor-comment"><p>2) Introduction: Addissie et al., 2020 should be referenced here. Also, recommend reviewing Addissie et al.</p></disp-quote><p>We agree the Addissie et al. paper is highly relevant to the discussion and have cited it twice in the text (Results section).</p><disp-quote content-type="editor-comment"><p>3) I do not believe there is sufficient evidence to associate CDON with HPE in humans. In the largest study mentioning CDON's association with HPE, some of the variants were (1) transmitted from a parent; and (2) a missense variant without functional evidence of pathogenicity. These CDON variants are variants of unknown significance. Commercial labs often misinterpret these gene associations with HPE and it is very important to be precise here, i.e. see https://www.invitae.com/en/physician/tests/04424/#info-panel-assay_information. See my next comment. I believe the author have misinterpreted the findings in Roessler, 2018a.</p><p>4) It should be noted that CDON loss of function variants are commonly found in healthy human individuals (observed / expected ration of 0.58; https://gnomad.broadinstitute.org/gene/ENSG00000064309?dataset=gnomad_r2_1), showing that CDON loss of function variants are not constrained by evolution. This is very important and it supports the authors' findings that most alcohol is needed with a CDON variant to reach the HPE threshold in mice and most likely (though not proven) in humans.</p></disp-quote><p>We have made the requested changes to the text (please see the response to Essential revisions, point 2, above).</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>[…]</p><p>1) Authors provide a nice set of data showing that ethanol inhibits SMAD2 C-terminal phosphorylation in mouse epiblast stem cells (Figure 2A, 2B). This is excellent. However, it is more important to see the effects of ethanol with mouse embryos. This can be done by staining of mouse embryos such as those shown in Figure 1 with the anti-phosphorylated SMAD2C (the antibody is commercially available and has been used by others). Similarly, I would like to suggest to examine p-SMAD2C in Cdon, Lrp2 double mutants embryos too (Figure 3A; whole mount staining may be easier at an earlier stage than E11.5). This would strengthen the conclusion that Cdon and ethanol synergistically affect Nodal signaling in mouse embryos.</p></disp-quote><p>In lieu of not performing these experiments immediately, we have made requested changes to the text (please see the response to Essential revisions, point 3, above). We will perform these experiments and report back as soon as possible.</p><disp-quote content-type="editor-comment"><p>2) Lefty2 expression is regulated by Nodal, but Lefty2 protein inhibits Nodal activity, which makes a complex network. It is preferable to examine additional Nodal target genes such as Gsc in Figure 1. Also, is Nodal expression maintained in Cdon<sup>-/-</sup>, EtOH embryos (Figure 1)?</p></disp-quote><p>We thank the reviewer for this comment. We have indeed assessed expression of <italic>Gsc</italic> and <italic>FoxA2</italic>. This was mentioned in the first version of the manuscript, but we have now made this clearer (please see the response to Essential revisions, point 4, above). We will assess Nodal expression at the same time we examine p-SMAD2C production in embryos and report back.</p></body></sub-article></article>